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Chiral synthons of chemical and biological importance have been synthesised using 
imidazolidinone and Evans’ oxazolidinone chiral auxiliaries (CA). The thesis comprises two 
parts, which were carried out at the Universities of Cape Town, RSA and University of 
Michigan in the USA.   
 
In part 1, carried out in the Chemistry Department of the University of Cape Town, an 
imidazolidinone-CA was utilised in developing a malonate-based methodology to synthesise 
compounds containing a quaternary stereogenic centre (QSC). With this methodology, a 
small library of malonate-based QSC-containing synthons has been synthesised in both high 
yields (> 87 %) and high stereoselectivities (dr, ≥ 93 : 7 %). The CA was cleaved using an 
EtSLi SNAc reaction followed by a double reduction using the Fukuyama protocol followed 
by NaBH4 to afford α,α’-disubstituted-2-hydroxy synthons in 55-65% yield over two steps 
respectively.  
 
In part 2, carried out in the Chemistry Department at the University of Michigan, the 
macrolide core (10) of lactimidomycin was synthesised for biological evaluation over 11-
linear steps in a 6.1 % overall yield. The synthesis exploited an Evans’ oxazolidinone-
mediated aldol reaction to construct the Evans syn-adduct, a Suzuki cross-coupling for the 
(E,Z)-diene construction, and an intramolecular Horner-Wadsworth-Emmons olefination for 
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Staying true to the struggle 
We will stay true to the struggle till it comes to the end 
We will fight till that last milligram of product is consumed 
We will push these arrows till they make sense 
We will blow our TLCs till the last breath 
We will not be intimidated by NMRs that don’t look like our desired products,  
and we won’t be put off by impurities that dominate our spectra 
We won’t be satisfied by low yielding reactions. 
No time to mourn for failed reactions, instead we press forward towards the higher prize, 
which is scientific TRUTH. 
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Eqn     Equation 
eq     equivalents  
Et     Ethyl 
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Hz     Hertz 
n-Hex     normal-Hexane 
HPLC     High performance liquid chromatography 
HRMS     High resonance mass spectrometry 
hr/hrs     Hour(s) 
HOBt     1-Hydroxybenzotriazole 
 
IR     Infrared spectroscopy 
 
J     Coupling constant 
 
KHMDS    Potassium hexamethyldisilazide 
 
LDA     Lithium diisopropylamide 
LiHMDS    Lithium hexamethyldisilazide 
 
MHz     Megahertz 
Mp     Melting point 
Me     Methyl 
mg     milligrams 
ml     millilitres 
mmHg     millimetre mercury 
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nm     nanometers 
NMR     Nuclear Magnetic Resonance 












p     para 
p     Pentet 
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q     quartet 
qd     quartet of doublets 
 
rt     Room temperature  
 
s     singlet 
sat.     Saturated 
NaHMDS    Sodium hexamethyldisilazide 
 
TBAF     Tetrabutylammonium fluoride 
TBAI     Tetrabutylammonium Iodide 
TES     Triethylsilane 
THF     Tetrahydrofuran 
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Chapter 1: Introduction 
1.1. Asymmetric Synthesis 
Asymmetric synthesis (AS), also known as stereoselective synthesis or asymmetric induction 
is a term that was first used by E. Fischer in his work on carbohydrates.1 AS is defined as the 
study of synthesising optically active compounds, and the first enantioselective synthesis 
example (by the standards of the time) was reported by Willy Marckwald in 1904 in which 
he decarboxylated an α,α’-disubstituted malonic acid in the presence of the chiral alkaloid 
brucine to obtain the product in 10 % ee, Scheme 1.1.1 Since then, chemists have sought 
out a greater understanding and synthesis of chiral compounds.  
 
Scheme 1.1: The first enantioselective synthesis by Willy Marckwald. 
 
Nature consists of a myriad of optically active compounds with attractive architecture as 
well as useful chemical and medicinal (pharmaceuticals) properties.2 Both academia and 
industry have worked tirelessly to access pivotal chiral compounds, and the organic 
literature attests to the interest in this topic. Many powerful asymmetric methods have 
emerged over the past century that are used in both academic and industry laboratories. 
Since the early days of drug-discovery more and more chiral compounds have been used to 
combat various diseases.2a Also, over the years there has been a steady increase in the use 
of non-racemic active pharmaceutical ingredients (APIs) on the market, Figure 1.1.2a This 
shift was brought about by the US Food and Drug Administration (FDA) having to move 
away from the use of racemates as drugs. The banning of thalidomide in the early 1960’s is 
a classical example of why the use of racemic drugs can be catastrophic, and the shift 













Figure 1.1: New chemical entities (NCEs) on the market as either single enantiomers or 
racemates.2a 
 
The synthesis of chiral compounds is far more challenging than the synthesis of their achiral 
counterparts, the main issue being the control of facial bias in the bond-forming step 
leading to high stereoselectivity. To this effect, the following strategies have been 
employed with great success for accessing chiral compounds in high stereoselectivity 
include chiral pool (CP), chiral catalysts (CC), and chiral auxiliaries (CA), Scheme 1.2.3 The CP 
strategy involves the use of a naturally abundant or easily accessible chiral compound that 
can be transformed into the target compound (Eqn 1). This strategy has been the method 
of choice especially in industry due to the abundance and accessibility of natural chiral 
starting materials.2a, 4 However, a drawback of this strategy is that not all target compounds 
resemble naturally occurring chiral compounds or can be accessed from naturally occurring 
starting materials. On the other hand, CC is the use of a chiral ligand (enzymatic, 
organometallic, and recently organocatalytic) in sub-stoichiometric amounts where the 
chiral ligand is recycled after the enantioselective asymmetric induction transformation, 
Eqn 2.3, 5 By comparison, CAs are used in stoichiometric amounts. The use of a CA is a three-
step process, in which the CA is firstly attached to the substrate, which is followed by 
diastereoselective asymmetric induction, and finally the CA is cleaved and recovered to 
obtain the product enriched in one of the enantiomers.1a, 3  
From now on, the CA strategy will be the focus of this review in view of its relevance to 
both research projects in this dissertation. Where necessary, the other two strategies (CP 












Scheme 1.2: Asymmetric synthesis strategies.6  
 
1.2. Chiral Auxiliaries 
As mentioned earlier, a CA-based method requires that the CA: (i) is attached to the 
substrate; (ii) induces high diastereofacial selectivity; and (iii) is removed and recovered 
without racemization of the newly formed stereocentre, Scheme 1.3.7 The effectiveness of 
a CA depends on the ease with which these three steps are performed and this criterion has 
been the basis of many successful and widely utilised CAs. For most, if not all CA-based 
methods, a C-X (X = O, N) covalent bond is used as a point of attachment between the 
substrate and the CA. This carbon-heteroatom bond is used because C-X bonds are easier to 
form, strong enough not to break during the asymmetric induction step, but can be cleaved 
relatively easily afterwards. Another heteroatom on the CA is typically used (especially in 











chelation is pivotal for acyclic CA-mediated reactions as it locks the “substrate-CA” species 
into one conformer, thus allowing facial bias leading to high diastereoselectivity.  
 
Scheme 1.3: CA-mediated asymmetric induction.1a  
 
The use of a CA dates back to the early 1970s from work done by Meyers with oxazolines, 
Scheme 1.4.8 In his studies he used readily available chiral (1S,2S)-1-phenyl-2-amino-1,3-
propanediol which he condensed with various nitrile salts forming a 5-membered oxazoline 
ring in 75 % yield. Subsequently, Meyers mono-alkylated the oxazolines with various 
electrophiles to afford 1 in high optical purity (de, 82 %) and high yields (62-92 %). Acid 
hydrolysis afforded α-alkylated carboxylic acid 2 in moderate to high yields (62-84 %).8  
 
Scheme 1.4: Oxazoline as CA in asymmetric induction.  
 
In order to explain the stereoselectivity, Meyers invoked a charge-assisted transition-state 
(TS) model involving a bicyclic chelating ring with the lithium cation, in which the Li+ ion 
coordinates to the nitrogen of the aza-enolate, the oxygen of the ether, as well as the 
leaving group of the electrophile on the re-face. This then assists the electrophile to 











step is favoured so as to minimise steric interaction between the chelated ring and the R-
substituent on the double bond. 
 
Figure 1.2: Meyers’ TS-model for oxazoline alkylation 
 
Following Meyers’ report, powerful CAs have emerged to provide a standard procedure for 
synthesising chiral compounds in both academic and industrial labs, Figure 1.3.2a The 
different CAs in Figure 1.3 complement each other in many ways. For example, while Evans 
and Evans-type CAs are mostly used in asymmetric aldol reactions,9 the cyclohexane-based 
ones (such as Hoffmann)10 are used in alkylation reactions, while the proline-based (such as 
Enders)11 are used in Michael additions. However, it must be said that CAs are meant to be 
widely used in many types of asymmetric reactions and so there is no CA that is only meant 
for a particular reaction-type. Instead, different groups have used CAs for various 
transformations depending on the availability of the CA and the research group’s interests. 
One of the reactions that CAs have been intensely utilised for, is the asymmetric aldol 












Figure 1.3: Examples of CAs that have been used in asymmetric synthesis.   
1.3. The aldol reaction 
Enolate chemistry has proven to be one of the most reliable tools for the synthesis of C-X (X 
= C, N, O, and halogen) bonds in organic synthesis.13 The aldol reaction, first discovered in 
the 19th century independently by Charles-Adolphe Wurtz and Alexander Borodin, is a sub-
class of enolate transformation in which an enolisable carbonyl compound acts as a 
nucleophile and adds to an electrophilic carbonyl group to give a β-hydroxycarbonyl 
product 3 which may eliminate to an α,β-unsaturated carbonyl 4, Scheme 1.5, Eqn 1.12 The 
reaction leading to 3 is called the aldol addition while the one leading to 4 is called the aldol 
condensation. The formation of product 3 or 4 depends on the carbonyl substrate(s) used 
and the reaction conditions. During an aldol addition reaction where two prochiral carbons 
in the bond-forming step are involved, two stereogenic centres are concomitantly formed 
contiguously, leading to four possible stereochemical outcomes, as the two syn-











(syn : anti ratio) in this reaction can be controlled by the choice of Lewis acid (via chelation), 
CA (vide infra), and the type of base used. 
 
Scheme 1.5: The aldol reaction syn- and anti-adducts.  
1.3.1. Zimmerman-Traxler transition-state model 
Since the use of preformed enolates in the 1970’s, various plausible TS-models have been 
proposed to elucidate the stereochemical outcome observed in the aldol addition 
reaction.12 Some of the proposed TS-models include the Zimmerman-Traxler,14 and 
Hoffmann15 to mention a few. Owing to relevance and generality, only the Zimmerman-
Traxler TS-model will be discussed. Also, the other models were only introduced to explain 
some results that could not be entirely understood with the Zimmerman-Traxler model.  
The Zimmerman-Traxler model invokes a six-membered chelating ring that incorporates 
both the nucleophilic enolate and the electrophilic carbonyl, as well as the enolate metal 
cation, Scheme 1.6. Enolisation of 5 can form either the E- or Z-enolate, which individually 
lead to different stereochemical products. Formation of the E-enolate leads to two possible 
TS-models, 6a and 6b, with 6a as the preferred model because the R1 substituent is in an 
equatorial position avoiding 1,3-diaxial interactions. This explains why E-enolates give 
predominantly anti-aldol products. By comparison, formation of the Z-enolate leads 











such a case the syn-aldol product is favoured. It is worthy to note that a combination of 
parameters such as Lewis acid, base, CA and so forth can be used to control the selectivity 
for either syn- or anti-adduct.  
 
Scheme 1.6: The Zimmerman-Traxler transition-state model for aldol addition.  
1.3.2. Chiral auxiliary mediated aldol reaction 
The CA-mediated asymmetric aldol reaction is one of the most important and reliable tools 
in asymmetric synthesis (AS) and has been used in many total synthesis of natural products 
and APIs (active pharmaceutical ingredients), especially polyketides possessing contiguous 
stereogenic centres.16 Evans has made a profound contribution in this field with his 
pioneering work on N-acyl oxazolidinone aldol addition reactions.9b-d To account for the 
stereochemical formation of his products Evans also invoked a Zimmerman-Traxler type-
model, Scheme 1.7. He proposed that the Z-enolate is preferentially formed due to 
minimised steric interactions between the R2- and R3-substituents. Once the enolate 
geometry is set, the CA carbonyl (C=X, X = O, S) can chelate to the metal (M = Ti) forming 
8a, which leads to the non-Evans syn-adducts.  Alternatively, it can not chelate to give 8b 











metals changes the π-facial selectivity of addition to the enolate, leading to opposite 
absolute configurations in the products. 
 
Scheme 1.7: CA-mediated TS-models for the Evans and non-Evans syn-adducts.  
 
Owing to relevance to the current research, only the syn-aldol products will be discussed. 
Table 1.1 is not exhaustive but seeks to highlight ways that have been used to access both 
Evans and non-Evans syn-products in high diastereoselectivity by simply varying reaction 
conditions. The non-chelation/chelation process (refer to Scheme 1.7) acts as a switch 
between the Evans syn- and non-Evans syn-products, and has been the main focus for 
research in this area.17 The extent of chelation depends on: the type of X atom, the Lewis-
acid metal M, and the excess amine base. Entry 1 depicts the pioneering work by Evans 
with boron enolates to attain the Evans syn-adduct (9b). Boron can only bond to four 
groups including coordination to the aldehyde carbonyl as part of the reaction activation. 
Hence, it cannot coordinate to the CA and the reaction proceeds via a non-CA chelated 
transition-state (TS) to give the Evans-syn product. Since alkali earth-metals (Li, Na, K) have 
a low coordination number they cannot coordinate to the CA either and therefore they all 
also afford the Evans syn-adduct. On the other hand, titanium has empty d-orbitals and can 
therefore coordinate to X leading to the chelated TS-model which gives the non-Evans syn-











adduct, entry 4. However, one can “switch-off” the titanium-chelation by using excess 
amine-base, which intercepts the chelation and in so doing reverts the reaction outcome 
back to the Evans syn-adducts, see entry 3.  
 
Table 1.1: The effects of reaction conditions on CA-mediated aldol addition reactions.12, 17  
  
Entry R3 X  Y Base (eq) Lewis Acid 
(eq) 
Ratio  
9a : 9b 
1 i-Pr O O i-Pr2NEt (1.1) (nBu)2B(OTf) 
(1.2) 
> 2: 98 
2 Bn O O i-Pr2NEt (1.1)  TiCl4 (1.1) 98 : 2 
3 Bn S S (-)-Sparteine 
(2.5) 
TiCl4 (1.0) 1 : 99 
4 Bn S S (-)-Sparteine 
(1.0) 
TiCl4 (1.0) 98 : 2 
 
1.4. Quaternary Stereogenic Centres 
Quaternary stereogenic centres (QSC) are ubiquitous both in nature and in the 
pharmaceutical industry. It is therefore imperative to come up with efficient methods that 
give access to this motif. The term quaternary centre is sometimes a cause of confusion 
because it is broad. Specifically, a QSC is a fully substituted chiral carbon without any 
carbon-hydrogen bond, and examples include oxaquaternary (a), aza-quaternary (b) and so 
forth, Figure 1.4.18 In this review the term QSC will refer strictly to an all-carbon quaternary 
chiral centre, such as the one in morphine, Figure 1.4. Although this research only concerns 
itself with QSC-containing compounds, where necessary, other types of quaternary centres 












Figure 1.4: QSC-containing compounds with the QSC shown by the arrow. 
 
The synthesis of chiral compounds is challenging but an even more demanding task is the 
synthesis of QSC-containing compounds.19 Construction of QSCs via a fully substituted sp2 
centre is well-known in organic synthesis, especially via enolate chemistry, and the two 
main challenges encountered in such a synthesis include: 1) the steric repulsion involved in 
bringing a fourth substituent to an already congested carbon centre, and 2) generation of a 
stereo-defined enolate (E-/Z-enolate), which is crucial for controlling the stereochemistry in 
the product.19 Owing to the demands mentioned above, QSC construction is then arguably 
a true test of existing asymmetric methods that have been developed for the synthesis of 
chiral tertiary centres. Constructing this motif is therefore crucial for advancing the 
repertoire of asymmetric synthesis (AS) methods.   
Indeed, powerful diastereoselective and enantioselective methods have emerged over the 
years to overcome the challenges encountered in QSC construction and examples include 
the use of reactions such as Michael additions,20 Diels-Alder,21 aldol,22 and enolate 
alkylations23 to mention a few. However, more efficient methods are still required to build 
on the current repertoire to speed-up the synthesis of pharmaceutical drugs and chemically 
vital advanced synthons. For the purpose of this report only diastereoselective non-catalytic 
enolate alkylation reactions of relevance to QSC construction will be reviewed and 
discussed.  
1.4.1. Bicyclic enolate alkylation for QSC construction 
The first diastereoselective CA-mediated via enolate alkylation towards QSC construction 
was reported by Meyers in 1984 in which a bicyclic ring-system was used to control the 











carboxylic acid with L-valinol to form bicyclic lactam 10.24 Dialkylation of 10 with various R-
groups gave QSC-containing compounds in high yield and stereoselectivity, Scheme 1.8. 
After quaternisation, the CA was removed with ease under acidic conditions to liberate an 
α,α’-disubstituted γ-keto acid 12 in high yield (70-90 %) and good stereoselectivity (> 90 % 
ee for some products). Changing the order of introduction of R- and R’-group inverts the 
stereochemistry in 12. 
 
Scheme 1.8: Reaction conditions- a) ∆, Tol/p-TsOH. b) i) LDA, –78 °C, THF; ii) R-X. c) LDA, –78 
°C, THF; ii) R’-X. d) 10 % H2SO4, ∆.  
 
The stereoselectivity of this strategy relies on the formation of a rigid/inflexible bicyclic 
structure which imposes particular geometry on the enolate, as well as the shielding of the 
exo-face by the bulky substituents, isopropyl and phenyl. The transition-state model (TS) 
invoked by Meyers involves the isopropyl and phenyl group shielding the top face of the 
enolate and thus directing alkylation with various R- and R’-groups to predominantly occur 












Figure 1.5: Meyers bicyclic enolate TS-model. 
1.4.2. Acyclic enolate alkylation for QSC construction 
The stereocontrolled alkylation of acyclic chiral enolates is more challenging than that of a 
bicyclic chiral enolate owing to the freedom of rotation in acyclic systems. Important 
factors that affect the stereochemical outcome in acyclic systems include the enolate 
geometry, steric effects and chelation effects. It is crucial to control the geometry of the 
forming E-/Z-enolate because alkylation of either isomer leads to different diastereomeric 
products. Unlike in bicyclic enolates where the enolate geometry is enforced by the bicyclic 
structure, in acyclic systems the enolate which is lower in energy is favoured. Steric 
interactions between the forming enolate and the group(s) on the CA favour formation of 
the enolate geometry lower in energy. Once the enolate geometry is set, steric hindrance 
from bulky-groups on the CA play a role in controlling the facial selectivity of addition to the 
enolate. Owing to the freedom of rotation in an acyclic system, strong chelation becomes a 
necessity so as to lock the already set enolate geometry into one conformer.  
A noteworthy example of an acyclic system utilised in QSC construction was reported by 
Myers with his studies using pseudoephedrine as a CA.25 α-Methylbutyramides 12a and 
12b, differing only in α-stereogenicity, undergo stereospecific enolisation with LDA at –40 
°C to the Z-enolate 13a and E-enolate 13b respectively. Benzylation of 13a and 13b with 
benzyl bromide at –40 °C is from the same face, away from the benzylic alkoxide, Scheme 
1.9. With this method various alkyl, allyl, and benzyl quaternised compounds were 











pseudoephedrine CA was removed via hydrolysis to carboxylic acid 15, or under reductive 
conditions with LiH2NBH3 to the primary alcohol 16.  
 
Scheme 1.9: Pseudoephedrine in QSC construction. 
 
To explain the observed stereospecific enolisation, Myers’ proposed a TS-model that is 
similar to Askin’s model with alkylating prolinol based enolates.26 The enolisation can be 
elucidated by a pre-transition state model (a steric-model) that requires the base to come 
from the opposite face of the benzylic alkoxide to avoid steric interaction, Figure 1.6.27 This 
TS-model suggests that the benzylic alkoxide coordinates to the THF solvent, blocking the 
top face and resulting the base coming in from the bottom face. During enolisation, 12a’ 
has the preferred conformation where the α-hydrogen atom is positioned on the opposite 
face to the benzylic alkoxide, and deprotonation leads to the Z-enolate. On the other hand, 
12b’ has the α-hydrogen on the same face as the benzylic alkoxide, thus a conformational 
change in the chain is required to position the α-hydrogen on the opposite face to the 












Figure 1.6: Stereospecific deprotonation. 
 
Myers confirmed the stereospecific enolisation by trapping the two enolates at –40 °C with 
dichloro(diisopropyl)silane to 17a and 17b and performing NOESY experiments on the silyl 
enol ether products, Scheme 1.10.  
 
Scheme 1.10: Silyl enolate trapping. 
1.4.3. Bicyclic thioglycolate enolate alkylation for QSC construction 
Gleason’s work on bicyclic thioglycolate is particularly interesting.28 Although it uses a 
bicyclic-lactam intermediate 18, similar to that of Meyers (vide supra), it is more subtle than 
that. Compound 18 was readily accessible over three steps in an overall yield of 71 % and 
was double alkylated as in Meyers’ bicyclic lactam to afford 19, the all-carbon QSC 
precursor. Compound 19 was then reduced under Birch conditions (Li/NH3) to afford the 
tetra-substituted chiral enolate 20, which was subsequently alkylated to the QSC-containing 
compound (21) in a one-pot reaction, Scheme 1.11. During quaternisation the free alkyl-SLi 
tether in 20 blocks one face of the enolate so that alkylation predominantly occurs on the 











acid hydrolysis to the carboxylic acid 22 in which the yields were low (≈ 20 %), or under 
reductive conditions which gave the primary alcohol 23 in good yield (≈ 74 %).  
 
Scheme 1.11: Reaction conditions- a) NaH, THF, rt. b) n-BuLi, L- valinol, THF, 0 °C. c) 
BF3•OEt2, DCM, rt. d) (i) LDA, LiCl, THF, 0 °C; (ii) R-X. e) (i) LDA, LiCl, THF, 0 °C; (ii) R’-X. f) (i) Li, 
NH3, THF, –78 °C; (ii) R”-X. g) 6M H2SO4, dioxane, ∆. h) LiH2NBH3, THF, –78 to 66 °C.  
 
In his articles,28 Gleason argued that the E-/Z-enolate geometry does not depend on the 
size of R- and R’-groups but solely depends on their order of introduction. He further 
suggested that the dihedral angle (O-C-C-S) on 19 is held as close as possible to 90° which 
ensures the stereospecific reductive enolisation, Scheme 1.12. Interestingly, Gleason’s 
strategy gives access to QSC synthons in high diastereoselectivity (de, > 87 %) without using 
the conventional methods such as bicyclic chiral enolates or acyclic chiral enolates. Apart 
from the drawback experienced in CA cleavage via acid hydrolysis to 22, Gleason’s method 












































Part 2: University of Cape Town research 
Chapter 2: Rationale for the research undertaken 
2.1. Overview 
As already discussed, the use of chiral auxiliaries (CA) has become a standard procedure for 
the synthesis of chiral compounds. CA-based methods are robust, scalable to industrial 
scale, and the CAs are usually relatively cheap and easy to synthesise from readily available 
chiral starting materials. Therefore, with this in mind our efforts in advancing the repertoire 
in asymmetric synthesis (AS) methods focused on the use of a CA. 
2.2. Objectives 
The main objective of this research project was to develop a method for constructing 
versatile synthons containing an all-carbon quaternary stereogenic centre (QSC) using a CA-
mediated reaction. With this objective in mind the two things that became crucial were the 
choice of substrate such that versatile synthons could be easily accessible, as well as the 
choice of the CA for stereoselective step.  
2.2.1. Malonates as versatile templates 
Malonate-based compounds are versatile, cheap and have a well-established chemistry 
repertoire such as chemoselective hydrolysis and reduction, enolate chemistry at the α-
position and sigmatropic rearrangements of allyl esters to mention just a few, Scheme 2.1. 
In light of these various possible reactions as well as examination of the literature failed to 
reveal any malonate system containing CA for asymmetric quaternisation, we became 













Scheme 2.1: Versatility of malonate esters. 
2.2.2. Evans and Evans-type CA in QSC construction 
Evans-based CAs (A and B) are popular for synthesising chiral, non-racemic tertiary centres 
and have a well-established chemistry. Surprisingly there were no reports found in the 
literature depicting an A- or B-mediated alkylation in malonate systems to construct a QSC 
on the Scifinder structure search tool, Scheme 2.2.  
 
Scheme 2.2: Quaternisation of A- and B-based CA systems. 
 
Thus, we decided to develop a malonate-CA method based on A and B for synthesising QSC-
containing synthons. Preliminary studies by a colleague in our labs established that 











product, Scheme 2.3. The CA elimination was observed on warming the alkylation reaction 
which was necessary for the reaction to proceed. On the other hand, when D was subjected 
to the same alkylation conditions no CA elimination was observed after warming the 
reaction to room temperature. With this knowledge then, current research focused on 
studying the quaternisation of α-substituted auxiliary-malonate systems. 
 
Scheme 2.3: Preliminary studies on oxazolidinone and imidazolidinone malonate-based QSC 
construction. 
2.3. The synthesis plan for constructing malonate-based QSC compounds 
Synthesis of α-substituted auxiliary malonate (2) involved a malonate mono-hydrolysis/ CA-
coupling sequence in which the R-group could be introduced early (starting with α-
substituted malonate – Route A) or late (alkylation of auxiliary-malonate – Route B), 
Scheme 2.4. From a cost perspective route A was preferred. However, both routes will be 











































Chapter 3: Results and Discussion 
3.1. Mono-hydrolysis of diethyl malonate 
The synthesis toward malonate-based quaternary stereogenic centres (QSC) commenced 
with the mono-hydrolysis of diethyl malonate (R = H) performed under basic-conditions 
(KOH) to afford monoacid 1a in excellent yield (90 %). The reaction was carefully monitored 
by TLC using an iodine stain so as to avoid formation of the diacid which would have 
involved a difficult separation of the mono- (Rf = 0.2 in 100 % EtOAc) from the diacid (Rf = 
0.1 in 100 % EtOAc) in product isolation.  
 
Scheme 3.1: Reaction conditions- a) KOH (2.5 M, in H2O), EtOH, 0 °C to rt. 
 
The formation of monoacid 1a was confirmed by its 1H NMR spectrum only, since it was a 
known compound. A conspicuous resonance at 9.75 ppm integrating for 1-proton 
confirmed the formation of one carboxylic acid group while a quartet at 4.23 ppm 
integrating for 2-protons and a triplet at 1.29 ppm integrating for 3-protons confirmed the 
presence of only one ethyl ester in 1a. The resonance at 3.40 (s, 2H) was assigned to the α-
methylene protons. 
3.2. Amide bond synthesis 
With the monoacid in hand the next step was to couple it to the CA – (4S,5R)-1,5-dimethyl-
4-phenylimidazolidin-2-one – using amide bond-forming chemistry. Over the years a 
plethora of methods have been developed for amide bond synthesis all of which involve 
activation of the carboxylic acid in preparation for a nucleophilic acyl substitution (SNAc), 
Scheme 3.2. The current research exploited 1-chlorobenzotriazole (BtCl) as a coupling 
agent, acyl chlorides and carbodiimide chemistry to synthesise the amide bond, and their 













Scheme 3.2: A general reaction for amide bond synthesis. 
3.2.1 BtCl in amide bond-formation 
There are various reaction methods based on using the benzotriazole moiety as a leaving 
group in which Katritzky et al has been the main research group in the field. Katritzky and 
our group have shown that a combination of triphenylphosphine and BtCl converts a 
carboxylic acid into its acyl Bt-derivative, which can subsequently be converted via a SNAc 
reaction into an amide, as well as other carboxylic derivatives, Figure 3.1.29  
  
Figure 3.1: Examples of acyl Bt-derivative reaction transformation. 
 
With that in mind, monoacid 1a was subjected to coupling with the imidazolidinone-CA 
using BtCl and PPh3 in a one-pot reaction. Although conversion to the acyl Bt-derivative 
occurred at room temperature according to TLC, the coupling (SNAc) step required heating 
in acetonitrile because the CA is a relatively poor nucleophile. In such a way, following 














Scheme 3.3: Reaction conditions- a) i) PPh3, BtCl, MeCN, 1a, 0 °C; ii) CA, MeCN, 84 °C. 
 
Of significance here was the coupling of a relatively poorly nucleophilic CA, and one is 
tempted to speculate that the N-acylation occurs through the relatively nucleophilic urea 
carbonyl oxygen, followed by a rearrangement, Scheme 3.4. Unfortunately, co-elution of 
the product with 1H-benzotriazole (BtH, a by-product) occurred as the desired product had 
a similar Rf to that of BtH – Rf values of 0.30 and 0.35 respectively in 40 % EtOAc in hexane 
– and this hampered isolation of 2a. Efforts to remove BtH with a KOH base-wash at 0 °C 
were unsuccessful in that trace amounts of BtH were still visible on TLC.  
The BtCl reaction mechanism (Scheme 3.4) begins with a reaction between 
triphenylphosphine and BtCl to give a chlorotriphenylphosphonium salt, in which the Bt 
anion is stabilised by resonance. Following proton-transfer between the acid and the Bt 
anion, nucleophilic substitution with the chlorotriphenylphosphonium salt ensues to afford 
an acyloxyphosphonium intermediate A, which then undergoes a rapid SNAc reaction with 
BtH to form the acyl Bt-derivative and triphenylphosphine oxide. The driving force in this 
step is the formation of the strong O-P bond in O=PPh3. Although intermediate B was not 
isolated, the TLC studies in 40 % EtOAc in hexane showed a spot with an Rf = 0.6 that 
initially formed and disappeared over time after adding the CA, and this supports Katritzky’s 
reports regarding its formation.29c, d Assisted by higher temperatures, the CA does a SNAc 












Scheme 3.4: The BtCl reaction mechanism. 
 
Synthon 2a was a new compound and was therefore fully characterised and confirmed by 
IR and NMR spectroscopy, elemental analysis, and [α]D obtained. The IR bands at 3008 (Ar), 
1736 (2 x C=O, amide and ester) and 1687 (C=O, urea) were observed confirming the 
various functional groups present in 2a. The absence of the CA-NH and the COOH 
resonance peaks in the 1H NMR spectrum confirmed the successful coupling of the 
imidazolidinone-CA to 1a. The 1H NMR spectrum revealed resonances at 7.35 (m, 3H, H-3’ + 
H-4’), 7.18 (m, 2H, H-2’), 5.32 (d, J = 8.7 Hz, 1H, H-1), 3.93 (dq, J = 8.7, 6.6 Hz, 1H, H-2), 2.81 
(s, 3H, H-4) and 0.80 (d, J = 6.6 Hz, 3H, H-3) confirming the CA in 2a, Figure 3.2. The H-2 
methine appears as a dq due to the vicinal H-1 coupling (J = 8.7 Hz) with a low dihedral 
angle (syn stereochemistry) while the smaller J = 6.6 Hz arose from coupling to the vicinal 
methyl group. The ethyl ester resonances were observed at 4.18 (q, J = 7.2 Hz, 2H, MeCH2O) 
and 1.26 (t, J = 7.2 Hz, 3H, MeCH2O). Two signlets at 4.02 and 3.97 ppm integrating for 2-
protons were assigned to the diastereotopic methylene H-a protons. The 13C NMR spectrum 
revealed three resonances at 167.7 (C=O, ester), 165.1 (C=O, amide) and 155.6 (C=O, urea) 











137 ppm region diagnostic for aromatic carbons confirmed the presence of the CA Ph-group 
while other CA resonances were observed at 59.5 (C-1), 54.2 (C-2), 28.3 (C-4) and 15.1 (C-3). 
The ethyl ester resonances were observed at 61.3 (MeCH2O) and 14.2 (MeCH2O) while the 
α-methylene carbon was observed at 43.5 ppm. Elemental analysis further confirmed the 
synthesis of 2a, with anal. calc. for C16H20N2O4 (%): C, 63.14; H, 6.61; N, 9.20 and found (%): 
C, 63.19; H, 6.57; N, 9.24 on a recrystallised sample.  
 
Figure 3.2: The 1H NMR spectrum for 2a.  
3.2.2. Acyl halides in amide bond-formation 
The BtCl-based amide coupling reaction did not work as well as anticipated in view of the 
modest 68 % yield due to the issue in product isolation by chromatography. An obvious 
alternative was to synthesise the amide bond via acyl activation with thionyl chloride 
(SOCl2). This method was not chosen initially in order to avoid distillation of the 
corresponding acyl chloride. To this effect, monoacid 1a was chlorinated with SOCl2 at room 
temperature after which DCM and excess SOCl2 were removed under reduced pressure on 
the rotary-evaporator and the acyl chloride residue directly used to acylate the 











for 2a (62 %) was obtained and that was reasoned to be because some of the acid chloride 
product may have escaped on the rotary-evaporator during removal of excess SOCl2.  
 
Scheme 3.5: Reaction conditions- a) SOCl2, DCM, rt. b) CA, MeCN, 84 °C.  
 
The low yield prompted a change to the α-substituted malonate-CA systems in which the 
acid chloride would have a higher boiling point and thus be separable from excess SOCl2 by 
distillation. Thus, α-substituted diethyl malonates were hydrolysed with KOH as outlined in 
Scheme 3.1 to afford the various monoacids in excellent yields (> 90 %). The α-substituted 
monoacids were also confirmed by 1H NMR spectroscopy only and resonance peaks 
assigned as outlined for 1a.  
Monoacid 1b was chlorinated with SOCl2 and the crude mixture distilled at atmospheric 
pressure under nitrogen with DCM and excess SOCl2 distilling off at 40 °C and 74-75 °C 
respectively.30 Acyl chloride 1b’ distilled off at 70-74 °C under reduced pressure (≈ 0.75 
mmHg) and was immediately used to acylate the CA to afford 2b after chromatography in 
an excellent yield of 90%, Scheme 3.6. The rapid synthesis of other α-substituted malonate-
CA derivatives was achieved similarly obtaining a range of α-substituted malonate-CA 
compound 2b-2e in excellent yields (> 89 %) and as a ≈50/50 mixture of diastereomers. 
  
Scheme 3.6: Acylation of the CA with α-substituted acyl chlorides.  
The formation of the acyl chlorides 1’ was confirmed by 1H NMR spectroscopy which 
showed a slight downfield shift of all the resonances compared to the monoacid 1 as well as 











All the α-substituted malonate-CA synthons were new compounds and were therefore fully 
characterised by IR and NMR spectroscopy, elemental analysis for 2b and 2c, HRMS for 2d 
and 2e, and [α]D. Spectroscopic assignments were made similarly to compound 2a. All the 
α-substituted malonate-CA compounds were obtained as a 50/50 mixture of diastereomers 
and this was expected because the α-substituted diethyl malonates used in the first step 
was a racemic mixture to begin with. 
After column chromatography, compounds 2b and 2c were obtained as solids while 2d and 
2e were obtained as colourless oils. The fractional recrystallisation of compounds 2b and 2c 
(in EtOAc/hexane) to a constant melting point enriched the mixture to only one 
diastereomer. Unlike enantiomers, diastereomers have different physical properties and 
can thus be separated by recrystallisation. This was the case for 2b and 2c, which was 
confirmed by the 1H NMR spectrum, which revealed a resolution of the doubled 
diastereomeric resonances at around 5.33, 4.65 and 2.82 ppm – compare Figures 3.3.1 and 
3.3.2.  
 
Figure 3.3.1: The 1H NMR spectrum for 2c before recrystallisation. The two-arrows depict 












Figure 3.3.2: The 1H NMR spectrum for 2c after recrystallisation.  
 
In spite of the excellent yields, this procedure was tedious and time-consuming. Also, acyl 
halides are toxic, easily hydrolysable in air and generally difficult to handle. Another set-
back with this method was that one could not synthesise 2a in high yield, the core 
intermediate for accessing a broad range of α-substituted malonate-CA compounds. 
Therefore, another method was sought to access 2a for which carbodiimide chemistry was 
chosen. 
3.2.3. Carbodiimide in amide bond-formation 
Like the other amide bond-forming reactions, the carbodiimide reaction relies on forming 
an activated intermediate (the O-acylurea) which activates the carboxylic acid by converting 
the hydroxy-group into a good leaving group.31 In this research N,N'-
dicyclohexylcarbodiimide (DCC) was utilised as the coupling agent to afford 2a after 
chromatography as an off-white solid in good yield (80 % yield), whose structure was 












Scheme 3.7: Reaction conditions- a) DCC, CA, DCM, BtOH (cat., 50 % mmol), 0 to 40 °C.  
 
The DCC reaction mechanism commences with a proton-exchange between 1a and DCC 
followed by the negatively charged acid adding to the carbodiimide species to give an O-
acylurea intermediate (a mixed anhydride). HOBt was added to avoid rearrangement of the 
O-acylurea intermediate to the N-acylurea by substituting the former to an 
acyloxybenzotriazole intermediate which is attacked by the CA.31 Once again, it is attractive 
to speculate that the coupling with the imidazolidinone-CA proceeds via the carbonyl urea 
oxygen followed by a rearrangement to form 2a, Scheme 3.8. Overall, the results obtained 
with DCC were far more satisfactory than the previously obtained results from the BtCl and 












Scheme 3.8: The DCC-coupling reaction mechanism.  
3.3. Synthesis of α-substituted malonate-CA compounds via alkylation  
For initiation of the alkylation studies, α-substituted malonate-CA compounds 2b-2f were 
also synthesised via alkylation of 2a with various electrophiles, Table 3.1. Preliminary 
studies with potassium hexamethyldisilazide (KHMDS) gave satisfactory results and thus 
other bases were not examined in this reaction. Reaction with iodomethane proceeded 
well to afford a diastereomeric mixture of 2b (90 % yield) as a colourless solid. Alkylating 
with longer alkyl inactivated electrophiles such as iodoethane, 1-bromobutane and 1-
bromohexane required heating the mixture at 66 °C, in which for 1-bromobutane and 1-
bromohexane an in situ iodine-bromine exchange via the TBAI salt was required for 
complete conversion of the starting material. Nevertheless, compounds 2c, 2d and 2e were 











Allylation with allyl bromide, a more reactive electrophile, proceeded well without refluxing 
or iodine exchange to give a diastereomeric mixture of 2f (87 %) as a colourless oil. It was 
pleasing to be able to install with ease various α-substituents on 2a as this could allow 
access to a wide variety of pivotal α-substituted intermediates as useful starting materials 
for the quaternisation.  
 
Table 3.1: Installation of the first α-group 
 
a) i) KHMDS, –78 °C, THF; ii) R-X, –78 to 66 °C.  
Compound Electrophile (R-group) Yield (%) dr (%) 
2b Methyl iodide 90 50 : 50c 
2c Ethyl iodidea 89 50 : 50c 
2e Butyl bromideb 87 50 : 50d 
2e Hexyl bromideb 90 51 : 49d 
2f Allyl bromide 87 50 : 50 c 
a Heat assisted. b Heat and TBAI assisted. c Observed by NMR. d Observed by HPLC after 
column chromatography. 
 
Installation of the first α-group was observed to be non-stereoselective and this was not 
considered to be an issue for the quaternisation step. As discussed in more depth in 
Chapter 1, the stereoselectivity of an acyclic enolate-based reaction depends on the 
stereoselectivity of formation of the E- or Z-enolate. The potassium cation has two possible 
chelation sites, site-A or site-B (depicted by arrows in Scheme 3.9) of which site-B is 
expected to be preferred because of the stronger donating effect from the nitrogen atom in 
the CA-urea moiety compared to that of the oxygen of the ester. During enolisation, the Z-











which the ester points away from the CA. Once the enolate geometry is set, the incoming 
electrophile approaches on the opposite face to that of the CA bulky groups. However, 
since the final products were obtained as a 50/50 mixture of diastereomers one may 
speculate that the E- and Z-enolates were formed in almost equal amounts. Also, 
epimerisation of the α-stereocentre post-alkylation cannot be ruled out. The subtleties of 
these mechanistic questions were not pursued any further as the purpose of this research 
was to study the synthesis of the QSC selectivity in the next step. The α-substituted 
malonate-CA compounds were characterised and confirmed as described above.  
 
Scheme 3.9: The TS-model for the first alkylation.  
3.4. Quaternisation of α-substituted malonate-CA compounds 
With regards to the objectives of the current research, the quaternisation step was the 
most crucial aspect. As discussed in Chapter 1, the stereoselectivity of quaternising an 
acyclic enolate depends on the enolate geometry, strong chelation effects as well as steric 
effects provided by bulky substituents on the CA. With that in mind a set of reaction 
conditions was sought that would enable access to QSC compounds in both high yield and 
stereoselectivity. 
3.4.1. Choosing the base for quaternisation  
In pursuing plausible reaction conditions for the QSC construction, a couple of bases were 
screened including lithium diisopropylamide (LDA), lithium hexamethyldisilazide (LiHMDS), 
sodium hydride (NaH), sodium hexamethyldisilazide (NaHMDS) and potassium 
hexamethyldisilazide (KHMDS), Table 3.2. All these bases are strong enough to completely 











can speculate that their ability to quaternise 2c under identical reaction conditions in the 
presence of an electrophile (benzyl bromide in this case) should only depend on the metal 
cation. 
Table 3.2 reveals that the reaction conversion increased with the size of the metal cation 
with only the K+ giving 100 % conversion (evaluated by TLC). The low reactivity of the 
lithium-enolate was thought to be due to the formation of a relatively stable lithium-
enolate conglomerate. The small lithium cation has several potential chelating partners 
(four oxygen atoms in 2c), so one may speculate a higher coordination to the Li+ which 
would lead to the congested inactive conglomerate.32 In this effect, core salts and core 
solvents have been used in various reactions to hinder the formation of conglomerates. 
Such studies were not pursued in this research, instead other bases were pursued. The 
sodium cation is larger and therefore promotes the formation of conglomerates to a lesser 
degree resulting in a slightly improved reaction conversion, entry 3 and 5. Finally, the 
potassium cation is much bigger resulting in a complete prevention of formation of the 
inactive conglomerates, thus the 100 % reaction conversion. Also, one cannot rule out the 
correlation between the reaction conversion (enolate reactivity) and the ionicity of the 
alkoxide metal bond (O-M). The O-M bond increases in ionicity from Li+ to K+, and the more 























Table 3.2: Screening different bases for QSC construction. 
 
a) i) Base (1.3 eq), –78 °C, THF; ii) BnBr, –78 °C to rt. 
Entry Base Reaction Conversion (%) 
1 LDA < 10a 
2 LiHMDS < 10a 
3 NaH 40a 
4 NaHMDS 50a 
5 KHMDS 100b 
a Observed by TLC after 72 hrs.b Within 20 hrs all the starting material had been consumed, 
observed by TLC. 
 
3.4.2. Quaternisation studies  
Now that suitable conditions had been established, KHMDS base was used throughout the 
research project for the construction of malonate-based QSC compounds. Low reaction 
conversion (< 30 % by TLC) were observed with moderately reactive electrophiles such as 
iodoethane and 1-iodopropane for quaternising R = Me and were therefore not pursued 
further. These quaternisation studies also revealed that allyl iodide was preferred to allyl 
bromide for R > Me. Thus, only reactive electrophiles quaternised the different α-
substituted malonate-CA compounds obtaining products in excellent yields after 

















Table 3.3: Constructing malonate-based QSC compounds. 
 
a) i) KHMDS , –78 °C, THF; ii) R’-X, –78 °C to rt. 
Compound R-group R’-group Yield (%) dr (%) 
3a Me Allyl bromide ― 51:49a 
3b Allyl Iodomethane 83 > 99:1b 
3c Et Iodomethane 95 > 99:1b 
3d Et Allyl iodide 92 95:5a 
3e Et Benzyl bromide 89 > 99:1b 
3f n-Bu Iodomethane 88 93:7a 
3g n-Bu Allyl iodide 85 > 99:1b 
3h n-Bu Benzyl bromide 84 > 99:1a 
3i n-Hex Iodomethane 90 > 99:1b 
3j n-Hex Allyl iodide 87 > 99:1a 
3k n-Hex Benzyl bromide 82 > 99:1a 
a Obtained by HPLC after column chromatography. b Obtained by 1H NMR spectroscopy. 
 
Compounds 3e and 3g were obtained as solids after column chromatography and were 
recrystallised in EtOAc/hexane to give crystals, of which 3g was suitable for analysis by an X-
ray evaluation. The X-ray data allowed identification of the absolute stereochemistry of 3g 
and this allowed a transition-state model to be proposed, Figure 3.4. Also, other crystal 












   
Figure 3.4: The crystal structure for 3g obtained by X-ray diffractometer.  
 
Adjusting the X-ray picture into the all cis-carbonyl conformation, one sees that the allyl-
group in the final product ends up on the same face as the bulky substituents in the CA. At 
first glance, this seems counterintuitive because one would expect the incoming R’-group to 
have an anti-relationship with the bulky substituents in the CA according to the Evans’ 
model developed for tertiary centres.33 There are two possible TS-models that explain the 
observed stereochemistry in the major product (3g), Scheme 3.10 (Eqn 1 and Eqn 2). If the 
Z-enolate forms then the CA swings around to minimise steric interaction between R (n-Bu) 
and the Ph-group on the CA forming the s-trans conformer (Eqn 1). Allylation of this 
enolates predominantly occurs from the underneath face, away from the CA bulky 
substituents and thus leads to 3g. On the other hand, if one assumes an auxiliary chelated 
TS-model then the E-enolate forms to minimise the steric interactions between R (n-Bu) the 
Ph-group on the CA. Chelation of the potassium cation to the CA-carbonyl locks the CA in 
one conformation and thus allowing allylation of the enolate to predominantly occur on the 












Scheme 3.10: The proposed TS-model for quaternisation.  
 
Such a model allows one to explain the low stereoselectivity obtained for 3a (R = Me; dr, 50 
: 49) where one may speculate that there was no preference in the formation of either E-/Z-
enolate because the R-group was not big enough to force E-enolate formation only. On the 
other hand, when the R-group is significantly larger than the ethoxycarbonyl grouping it 
positions itself away from the CA thus minimising steric interactions, resulting in high 
stereoselectivity for R > Me. The best selectivity (> 99 : 1) was observed with R = n-Bu, n-
Hex (3h, 3j, 3k). Since there was no stereoselectivity for 3a, compound 3b was synthesised 
by reversing the order of introduction of R- and R’-group so as to get the spectroscopic 
data. 
The QSC-containing synthons were all new compounds and were fully characterised by IR 
and NMR spectroscopy, elemental analysis (for 3e and 3g) and HRMS (for oils), and [α]D. 
Only the spectroscopic data for 3e will be discussed in detail as a representative case, 
Figure 3.5. Diagnostic IR stretches were observed at 3008 (Ar), 2998 (Bn), 1732 (2x C=O, 
amide and ester) and 1689 (C=O, urea) for the functional groups in 3e. The CA and ethyl 
ester resonances were observed as before in the 1H NMR spectrum, while the α-ethyl 
protons were observed at 1.91 (m, 2H, H-b) and 0.87 (t, J = 7.5 Hz, 3H, H-a). The 











resonance observed as a broad singlet at 3.37 ppm integrating for 2-benzylic methylene 
protons confirmed the quaternisation with the benzyl group to 3e. Also, an extra set of 
peaks integrating for 5-protons was observed in the aromatic region further confirming 
introduction of the benzyl group. Carbonyl resonances were observed in the 13C NMR 
spectrum similarly as before at 171.5 (C=O, ester), 169.8 (C=O, amide) and 155.3 (C=O, 
urea). New resonances observed in the aromatic region 136.7 (C-1”), 130.7 (C-2”), 127.8 (C-
3”) and 126.41 (C-4”) as well as the methylene benzylic carbon at 39.5 (C-d’) confirmed the 
introduction of the benzyl group. The α-ethyl resonances were observed at 26.6 (C-b) and 
9.1 (C-a) in the 13C NMR spectrum. The formation of 3e was further confirmed by elemental 
analysis: anal. calc. for C18H24N2O4 (%): C, 71.07; H, 7.16; N, 6.63 and found (%), C, 70.81; H, 
7.05; N, 6.54. 
  
Figure 3.5: The 1H NMR for compound 3e.  
 
Owing to the sterically congested environment around the QSC in 3e, the initial 13C NMR 
spectrum (in CDCl3) on recrystallised material was complicated, portraying broad signals, 
and this was speculated to arise because of different conformational isomers. To eliminate 











temperature (35 °C) to overcome the rotational barrier. Indeed, at this temperature 
(though only a 5 °C increase) the broad signals resolved into single resonance peaks, 
compare Figures 3.6.1 and 3.6.2. The different conformational isomers observed for 3e in 
the 13C NMR spectrum attests to the steric challenge encountered in constructing the QSCs 
and also illustrates the elegance of the current method. 
 













































































Figure 3.6.2: The 13C NMR spectrum of 3e at 35 °C. 
 
3.5. Cleaving the imidazolidinone-CA 
As described in Chapter 1, the effectiveness of a CA-based method depends on the ease 
with which the following steps are performed: 1) coupling the CA to a substrate, 2) 
stereoinduction such that high diastereomeric ratios are obtained, and 3) the cleavage of 
the CA to obtain the enantioenriched product with recovery of the CA. The first two steps 
had been performed well thus far and the products were obtained in good yields - 
malonate-CA compounds (2) were obtained in > 87 % yield while QSC-containing synthons 
(3) were obtained in > 82 % yield with dr ≥ 93 : 7. Various reaction conditions were sought 
for a facile cleavage of the imidazolidinone-CA such that the QSC-containing compounds 
could be obtained in good yield while recovering the CA. An acceptable QSC-containing 
target compound was 6, Scheme 3.11. The main challenge in this transformation, however, 
was the relatively non-trivial chemo-differentiation of the amide from the ester functional 
























































Scheme 3.11: The desired QSC-containing synthon. 
3.5.1. Reductive cleavage of the CA 
Reductive cleavage was investigated first because of the possibility of obtaining the desired 
alcohol in just one step. The reductive cleavage reactions investigated included the use of 
NaBH4, LiBH4, DMS-BH3, DIBAL and LiAlH4 in which 3j (R = n-Hex, R’ = allyl) was the model 
substrate chosen, Table 3.4. No reaction was observed with NaBH4 in MeOH at 66 °C after 
48 hrs and the starting material was recovered. This was attributed to the low reactivity of 
NaBH4 and thus more reactive reducing agents were pursued. A LiBH4 (2.5 eq) reduction at 
0 °C revealed complete conversion of starting material after 3hrs, but the TLC reaction 
profile was complicated with streaks and several spots which made the isolation of the 
product difficult. The complicated TLC profile suggested that LiBH4 had reduced all of the 
carbonyl groups including the ester, amide and urea. The cleaved CA was visible on TLC (Rf 
= 0.2 in 40 % EtOAc in hexane) giving a bright yellow stain when sprayed with p-
anisaldehyde. Lower temperatures (–20 and –40 °C) were utilised to improve the 
chemoselectivity, and although the TLC profiles were slightly better than before in that the 
streak had disappeared, several close spots were still visible that made the isolation of the 
product difficult. Also, not all of the starting material was consumed even after 24 hrs (< 50 
% reaction conversion). Efforts to separate and recover the starting material, 
imidazolidinone-CA, and what was thought to be the product were unsuccessful and thus 

















Table 3.4: Reductive cleavage  
 
R = n-Hex, R’ = Allyl 
Entry Reduction agent Reaction Conditions Conclusion 
1 NaBH4 3j, 0 to 66 °C, MeOH, 48 hrs No reaction 
2 LiBH4 3j, –20 °C, Et2O, 24 hrs Complex TLC 
3 DMS-BH3 3j, –20 °C, THF, 8 hrs Complex TLC 
4 DIBAL  3j, –78 to 66 °C, THF, 24 hrs  Complex TLC 
5 LiAlH4 3j, –78 °C, THF, 15 min  Complex TLC 
 
A DMS-borane reductive cleavage was thus performed at 0 °C and within 2 hrs all the 
starting material had been consumed to reveal a complicated TLC profile. Unlike in the 
LiBH4 reduction, this time there was no sign of the CA on the TLC plate at Rf = 0.2 (in 40 % 
EtOAc in hexane), but a major product spot with Rf = 0.3 was observed. Another reaction 
was conducted at –40 °C to improve the TLC plate profile and the reaction was complete 
within 8 hrs. Indeed the TLC plate was not as complicated as before but still there was no 
sign of the CA at Rf = 0.2. The major product spot obtained after chromatography through 
its 1H NMR spectrum, revealed that the ethyl ester was not reduced and that the CA was 
indeed still attached to the substrate. Two extra set of resonance peaks in the 1H NMR 
spectrum at 3.49 and 2.28 ppm each integrating for 2-protons suggested that the amide 
and the urea carbonyl groups had been reduced. This was not surprising, since borane-
based reducing agents are known to chemoselectively reduce amides and ureas to form 
amines via carbonyl complexation.3 This was unsatisfactory and therefore the DMS-borane 
reduction was also abandoned.  
Since no concrete results were obtained with boron-based reducing agents, aluminium-
based reducing agents were therefore utilised and the first one tried out was a DIBAL 
reduction, which was conducted with 2.5 equivalents of DIBAL at –78 °C in THF. There was 











were slowly warmed to rt (over 3 hrs) to no avail. After 2 hrs at rt, the reaction contents 
were refluxed overnight, which resulted in < 5 % reaction conversion. On the TLC plate 
there was a faint UV-active spot forming just below the starting material with Rf = 0.4 (in 40 
% EtOAc in hexane) but no sign of the CA at the diagnostic Rf. The faint UV-active spot was 
speculated to be the corresponding aldehyde forming from ester reduction. The reaction 
was not pursued further so finally a lithium aluminium hydride reaction was carried out. A 
LiAlH4 reduction was not chosen initially because LiAlH4 is a strong and highly reactive 
reducing agent with the possibility of reducing all the carbonyl functional groups in 3j, 
resulting in the destruction of the chiral centre. A LiAlH4 (0.6 eq) reduction in THF was 
conducted at –78 °C and within 15 minutes all of the starting material had been consumed, 
with the TLC profile showing a complicated streak with no sign of the CA at the diagnostic 
Rf region in 40 % EtOAc in hexane. It was reasoned that the LiAlH4 had reduced all carbonyl 
groups including the urea on the CA. 
3.5.2. Base hydrolysis   
Another route pursued to cleave the CA involved base hydrolysis utilising LiOH, NaOH or 
KOH. This method was not chosen initially because such bases were speculated to be non-
chemoselective. Also, even if the chemoselective hydrolysis of the CA was achieved one 
would have to further reduce the monoacid formed to the alcohol and this would add an 
extra step to the synthesis. Another concern was that under basic conditions sterically 
congested half-acids such as 3 may decarboxylation to relieve steric strain. As suspected, 
base hydrolysis also proved to be unsatisfactory in that low conversions (< 50 %) were 
observed in which the diacid was always formed, and efforts to separate the mono- from 
the diacid by chromatography were unsuccessful. Nevertheless, it is noteworthy that the CA 
could easily be recovered (85 % yield, corrected) without the use of column 
chromatography by simply removing the EtOH under reduced pressure and using an acid-
base extraction.  
3.5.3. The CA cleavage via SNAc reaction via EtSLi 
RSLi has recently gained prominence in oxazolidinone cleavage via SNAc as it provides a 











including reduction to the aldehyde and hydrolysis to mention just a few.34 This EtSLi route 
was not chosen initially because it requires a three-step process to transform 3 to the 
desired alcohol 6.  
Reaction of 3 with EtSLi (2.5 eq) in THF at 60 °C revealed chemoselectivity once again to be 
a challenge as judged by the formation of the dithioester observed by running a 1H NMR 
spectrum on the crude material after a work-up. Optimisation studies revealed that it was 
necessary to have a high number of equivalents (10 eq) of EtSLi, which resulted in shorter 
reaction times with no formation of the dithioester. The temperature also played a pivotal 
role in these reactions, and an optimum temperature of 40 °C was found to minimise 
dithioester formation. Results using these optimised conditions are shown in Table 3.5 in 
which reaction times were found to be substrate-dependent in which there was a 
correlation with the degree of steric congestion at the QSC. In all cases the CA was 
recovered with > 80 % yield. 
 
Table 3.5: The SNAc reaction via EtSLi 
 
a) i) EtSH (10.5 eq), n-BuLi (10 eq), THF, –78 °C, 30 min; ii) 3 in THF, –78 to 40 °C, 2-5 hrs 
Compound Product R-group R’-group Reaction Time 
(hrs) 
Yields (%) 
3e 4a Et Bn 5 82 
3f 4b n-Bu Me 2 77 
3j 4c n-Hex Allyl 4 89 
 
The respective thioester compounds were all oils and thus fully characterised by IR and 
NMR spectroscopy, HRMS, and [α]D. Only compound 4a will be discussed as a 
representative case. The IR bands of 4a were observed at 2999 (Bn), 1742 (C=O, ester) and 
1691 (C=O, thioester) confirming the presence of these functional groups. The 











appearance of the new thioethyl resonances at 2.92 (q, J = 7.2 Hz, 2H, MeCH2S) and 1.26 
ppm (t, J = 7.2 Hz, 3H, MeCH2S) in the 
1H NMR spectrum confirming 4a. The ethyl ester, α-
ethyl and benzyl resonances were observed and assigned similarly as before. The 13C NMR 
spectrum also showed the disappearance of the CA carbons while all the other resonances 
were assigned similarly as in 3e. Three new resonances were observed at 199.2 (C=O, 
thioester), 23.7 (MeCH2S) and 14.1 (MeCH2S) in the 
13C NMR spectrum for the ethyl 
thioester and further confirmed the facile cleavage of the CA. The structure was further 
confirmed by mass spectrometry for which HRMS (ES): m/z calc. 295.1363 for C16H22O3S, [M 
+ H]+ requires 295.1370. 
3.6. Chemoselective reduction of the thioester  
Now that thioester 4 was in hand, a chemoselective reduction of the thioester was 
envisioned to be possible via DIBAL reduction of thioesters to aldehydes.35 The DIBAL (1.5 
eq) reaction was conducted at –78 °C in DCM and kept at this temperature for 3 hrs, but no 
reaction was observed so the temperature was slowly increased to rt over 3 hrs. After three 
more hours at rt reaction was observed after which the contents were then left overnight 
at rt. After 24 hrs a 40 % reaction conversion was observed by TLC, for which the crude 1H 
NMR spectrum revealed the reduction of both the ester and the thioester. The non-
chemoselective reduction is thought to be due to the increased temperature, but that was 
necessary as there was no reaction observed at lower temperatures. 
Since the DIBAL reduction was unsuccessful, another method was sought to 
chemoselectively reduce the thioester in the presence of the ester. In the event, 4a was 
subjected to the Fukuyama reduction protocol involving reduction with triethylsilane and 
Pd/C, which resulted in complete conversion of starting material within 2 hrs at rt.36 
Aldehyde formation was confirmed by the crude 1H NMR spectrum which showed a 
conspicuous aldehyde resonance at around 9.80 ppm, Scheme 3.12. Efforts to purify 
aldehyde 5a by column chromatography were unsuccessful and therefore was subjected to 
a further reduction with NaBH4 to afford alcohol 6a (66 % yield) over two steps. Thioester 
4b was also subjected to the same double sequential reductive conditions to obtain the 











two-step process were consistent with the TLC reaction profile which showed several spots, 
and one is also tempted to speculate aldehyde instability to be a cause for the moderate 
overall yield.  
 
Scheme 3.12: Reaction conditions- a) Pd/C, Et3SiH, THF, rt. b) NaBH4, 5, THF, 0 °C to rt. 
 
Subjecting thioester 4c containing an allyl group to the Fukuyama reduction conditions 
resulted in the reduction of both the thioester and the allyl group, Scheme 3.13. This was 
revealed by the crude 1H NMR spectrum which showed the appearance of the aldehyde 
resonance at 9.84 ppm as well as the disappearance of the allyl resonances at 5.61, 5.09 
and 2.71 ppm, Figure 3.7. This was not surprising because Pd (0) is used in various 
hydrogenation reactions of alkenes, but it was hoped that the thioester would be reduced 
faster than the allyl group. In fact the crude 1H NMR spectrum suggested that the allyl 
reduction was faster than the thioester as some of the thioester resonances were still 
observed at 2.90 ppm when the olefin resonances had completely disappeared. Reduction 
of compound 4c was not pursued any further.  
 












Figure 3.7: Crude 1H NMR spectra of 4c under Fukuyama reduction.  
 
The Fukuyama reduction is thought to proceed in a similar fashion to olefin cross-coupling 
reactions such as the Suzuki cross-coupling, in which the first step is the oxidative insertion 
of the thioester to Pd (0) forming Pd (II), Scheme 3.14. This is followed by reduction of the 
Pd-S bond forming species B, the organopalladium complex, which then undergoes 












Scheme 3.14: The Fukuyama thioester reduction. 
 
IR bands observed at 3339 (OH), 3002 (Bn), and 1713 (C=O, ester) confirmed the functional 
groups in 6a. The new resonances in the 1H NMR spectrum observed at 3.71 (d, J = 11.2 Hz, 
1H) and 3.51 (d, J = 11.2 Hz, 1H) were assigned to the diastereotopic (AB) methylene 
protons (CH2OH) due to the reduced thioester group, Figure 3.8. Similarly, the 
diastereotopic (AB) benzylic resonances were observed at 3.08 (d, J = 12.8 Hz, 1H) and 2.86 
(d, J = 12.8 Hz, 1H). The high JAB values (11.2 and 12.8 Hz) observed are indicative of the 
geminal coupling of diastereotopic protons. The –OH resonance at 2.15 ppm further 
confirmed the product. The replacement of the thioester carbonyl at 199.2 ppm by a 
methylene carbon at 63.6 (CH2OH) resonance in the 
13C NMR spectrum confirmed the 
formation of 6a. All the other 1H NMR and  13C NMR spectrum resonances were observed 





































Chapter 4: Conclusions and Future work 
4.1. Conclusions 
An imidazolidinone chiral auxiliary (CA) method has been developed for the synthesis of 
quaternary stereogenic centres (QSC) based on malonate substrates. A range of α-
monosubstituted malonate-CA compounds (2b-2f, > 89 % yield) was synthesised in 
preparation for the QSC construction. The non-trivial quaternisation of the α-
monosubstituted malonate-CA was achieved accessing a small library of malonate QSC-
containing synthons (3) in good yield (> 82 %) and good stereoselectivity (dr, ≥ 93 : 7 %).  
From quaternisation studies it is evident that:  
1) The second substituent R’ must be introduced as a highly activated electrophile such 
as iodomethane, allyl iodide or benzyl bromide. 
2) For high stereoselectivity R should be greater than Me, where exceptional selectivity 
was observed for R = n-Hex (dr, > 99 : 1).  
The CA could be cleaved from the products using the EtSLi SNAc reaction followed by a 
double sequential reduction via a Fukuyama protocol followed by NaBH4 to afford the α,α’-
disubstituted-2-hydroxy synthons (6a and 6b). 
 
Scheme 4.1: The synthesis of advanced QSC-containing synthons. 
4.2. Future work 
Moving forward with the research project would include derivatising the other malonate-
QSC compounds into 6, including finding compatible reaction conditions for allyl-containing 
synthons which are hydrogenated in the Fukuyama protocol. The QSC-containing advanced 
synthons such as 6 can be used in the synthesis of natural compounds and pharmaceuticals 












Scheme 4.2: The versatility of compound 6 explored.  
 
Also, one could vary the R- and R’-substituents using electrophiles such as Michael-
acceptors, acyl halides, aldehydes, crotyl-derivatives and so forth to access an even broader 
library. Preliminary studies based on TLC have shown positive results in quaternisation with 























Chapter 5: Experimental 
5.1. General 
All reaction solvents were freshly distilled under nitrogen, in which THF was distilled from 
sodium wire with benzophenone, MeCN distilled from calcium hydride, and DCM distilled 
from phosphorus pentoxide. Reagents were obtained from commercial sources (Sigma–
Aldrich, Fluka, Merck, Kimix) and used as obtained unless stated.  
All reactions were carried out in oven-dried glassware with a magnetic stirrer, and 
performed under a nitrogen atmosphere unless otherwise stated. Reaction temperatures 
were achieved with heat/silicone oil (for > 25 °C), ice/NH4Cl salt (for 0 °C), and 
acetone/liquid nitrogen (< -20 °C). Aqueous solutions were prepared using deionized water.  
All reactions were monitored by TLC using aluminium-backed Merck silica-gel 60 F254 
plates, and column chromatography was carried out using Kieselgel 60 silica-gel (Merck). 
Active compounds were observed under UV-lamp (ultraviolet), while non-UV active 
compounds were sprayed with a 2.5% solution of p-anisaldehyde in a mixture of sulphuric 
acid and ethanol (1:10 v/v), iodine vapour, or ceric ammonium sulphate solution and then 
heated.  
Nuclear Magnetic Resonance (NMR) spectra were recorded on either a Bruker XR400 MHz 
spectrometer (1H at 399.95 MHz and 13C at 100.6 MHz), Varian Mercury XR400 MHz 
spectrometer (1H at 399.95 MHz and 13C at 75.46 MHz), or a Varian Mercury XR300 MHz 
spectrometer (1H at 300.08 MHz and 13C at 75.46 MHz). Chemical shifts (δ) and J-coupling 
values were reported in units of ppm and Hz respectively. Chemical shifts for 1H and 13C 
were recorded relative to residual chloroform, 7.26 and 77.16 ppm respectively. High 
resolution mass spectra (HRMS) were recorded on a VG70 SEQ micromass spectrometer in  
electrospray positive mode. Elemental analyses were performed using a Fisons EA 1108 
CHNS elemental analyzer. Infra-Red (IR) spectroscopy was performed on a Bruker FT-IR 
Spectrometer with vibrations measured in units of   cm-1. Optical rotations were obtained 
using a Perkin Elmer 141 polarimeter at 20 °C and are reported as:     











Determination of melting points was done using a Reichert-Jung Thermovar hot stage 
microscope (HSM) and are uncorrected 
5.2. Monohydrolysis of diethyl malonates  
A representative typical procedure described below was followed for monohydrolysis 
diethyl malonates:37 
3-Ethoxy-3-oxopropanoic acid (1a)  
 
To a solution of diethyl malonate (8.0 g, 49.9 mmol) in EtOH at 0 °C, was added dropwise a 
solution of aq. KOH (24.0 ml, 59.9 mmol, 1.2 eq, 2.5 M) and the contents allowed to slowly 
warm up to rt. After 1 hour EtOH was removed under reduced pressure, the concentrate 
diluted with water (25 ml) and washed with DCM (2 × 25 ml). The aqueous layer was 
acidified with conc. HCl to pH = 2 and the re-extracted with DCM (3 × 30 ml), the organic 
extracts combined, dried over MgSO4, filtered under vacuum, and concentrated in vacuo to 
obtain 1a (5.9 g, 90 % yield) as a colourless oils.  
1H NMR (400 MHz, CDCl3) δ 9.75 (bs, 1H, COOH), 4.23 (q, J = 7.2 Hz, 2H, MeCH2O), 3.42 (s, 
2H, H-a), 1.29 (t, J = 7.2 Hz, 3H, MeCH2O). 
 
2-(Ethoxycarbonyl)propanoic acid (1b)  
 
Following the procedure outlined above: diethyl 2-methylmalonate (8.0 g, 45.9 mmol) and 
KOH (22.0 ml, 55.0 mmol, 1.2 eq, 2.5 M) were reacted in EtOH (20 ml) to obtained 1b as a 
colourless oil (6.3 g, 94 % yield). 
1H NMR (300 MHz, CDCl3) δ 9.23 (bs, 1H, COOH), 4.20 (q, J = 7.2 Hz, 2H, MeCH2O), 3.46 (q, J 













2-(Ethoxycarbonyl)butanoic acid (1c)  
 
Following the procedure outlined above: diethyl 2-ethylmalonate (8.0 g, 42.5 mmol) and 
KOH (20.4 ml, 51.0 mmol, 1.2 eq, 2.5 M) were reacted in EtOH (20 ml) to obtained 1c as a 
colourless oil (6.5 g, 95 % yield).  
1H NMR (300 MHz, CDCl3) δ 9.54 (bs, 1H, COOH), 4.22 (q, J = 7.2 Hz, 2H, MeCH2O), 3.31 (t, J 
= 7.2  Hz, 1H, H-c), 1.96 (m, 2H, H-b), 1.28 (t, J = 7.2 Hz, 3H, MeCH2O), 1.00 (t, J = 7.2 Hz, 3H, 
H-a). 
 
2-(Ethoxycarbonyl)hexanoic acid (1d)  
 
Following the procedure outlined above: diethyl 2-butylmalonate (8.0 g, 37.0 mmol) and 
KOH (17.8 ml, 44.4 mmol, 1.2 eq, 2.5 M) were reacted in EtOH (20 ml) to obtained 1d as a 
colourless oil (6.6 g, 97 % yield). 
1H NMR (400 MHz, CDCl3) δ 10.84 (bs, 1H, COOH), 4.21 (q, J = 7.2 Hz, 2H, MeCH2O), 3.36 (t, J 
= 7.2 Hz, 1H, H-e), 1.96-1.86 (m, 2H, H-d), 1.40-125 (m, 4H, H-b + H-c), 1.27 (t, J = 7.2 Hz, 3H, 
MeCH2O), 0.90 (t, J = 7.2 Hz, 3H, H-a). 
 












Following the procedure outlined above: diethyl 2-hexylmalonate (8.0 g, 32.7 mmol) and 
KOH (39.3 ml, 15.7 mmol 1.2 eq, 2.5 M) were reacted in EtOH (20 ml) to obtained 1e as a 
colourless oil (6.6 g, 93 % yield). 
1H NMR (400 MHz, CDCl3) δ 4.18 (q, J = 7.2 Hz, 2H, MeCH2O), 3.31 (t, J = 7.6 Hz, 1H, H-g), 
1.88 (q, J = 7.6 Hz, 2H, H-f), 1.35-1.25 (m, 8H, H-b to H-e), 1.26 (t, J = 7.2 Hz, 3H, MeCH2O), 
0.88 (t, J = 7.2 Hz, 3H, H-a). 
5.3. Synthesis of α-substituted acyl chlorides 
A representative typical procedure described below was followed to chlorinate the 
monoacids:30 
Ethyl 3-chloro-2-methyl-3-oxopropanoate (1b’)  
 
To a solution of monoacid 1b (5.0 g, 34.2 mmol) in DCM (30 ml), was added SOCl2 (4.9 ml, 
68.4 mmol, 2.0 eq) dropwise at 0 °C and the reaction contents allowed to warm up to rt. 
After 4 hrs, DCM and excess SOCl2 were removed via distillation under nitrogen in 
atmospheric pressure and the crude residue further purified by distillation in vacuo (≈ 1 
mmHg) to obtain acid chloride 1b’ (4.3 g, 77 % yield). Compound 1b’ was confirmed by 1H 
NMR only and immediately used to acylate the (4S,5R)-1,5-dimethyl-4-phenylimidazolidin-
2-one CA. 
1H NMR (300 MHz, CDCl3) δ 4.31-4.22 (m, 2H, MeCH2O), 3.84 (q, J = 7.2 Hz, 1H, H-b), 1.53 
(d, J = 7.2 Hz, 3H, H-a), 1.31 (t, J = 7.2 Hz, 3H, MeCH2O). 
 
Ethyl 2-(chlorocarbonyl)butanoate (1c’)  
 
Following the procedure outlined above: 1c (5.0 g, 31.2 mmol) and SOCl2 (4.5 ml, 62.4 
mmol, 2.0 eq) were reacted in DCM (20 ml) to obtain 1c’ (3.9 g, 70 % yield) which distilled 











1H NMR (400 MHz, CDCl3) δ 4.27-4.15 (m, 2H, MeCH2O), 3.65 (t, J = 7.2 Hz, 1H, H-c), 2.10-
1.85 (m, 2H, H-b), 1.26 (t, J = 7.2 Hz, 3H, MeCH2O), 0.98 (t, J = 7.2 Hz, 3H, H-a). 
 
Ethyl 2-(chlorocarbonyl)hexanoate (1d’)  
 
Following the procedure outlined above: 1d (5.0 g, 26.6 mmol) and SOCl2 (3.8 ml, 53.1 
mmol, 2.0 eq) were reacted in DCM (20 ml) to obtain 1d’ (4.5 g, 82 % yield) distilled at 100-
102 °C in vacuo as a yellow liquid. 
1H NMR (400 MHz, CDCl3) δ 4.24 (m, 2H, MeCH2O), 3.72 (t, J = 7.2 Hz, 1H, H-g), 1.97 (m, 2H, 
H-f), 1.46-1.30 (m, 4H, H-b + H-c), 1.28 (t, J = 7.2 Hz, 3H, MeCH2O), 0.90 (t, J = 7.2 Hz, 3H, H-
a). 
 
Ethyl 2-(chlorocarbonyl)octanoate (1e’).  
 
Following the procedure outlined above: 1e (5.0 g, 23.1 mmol) and SOCl2 (3.3 ml, 46.2 
mmol, 2.0 eq) were reacted in DCM (20 ml) to obtain 1e’ (4.1 g, 75 %) distilled at 138-140 °C 
in vacuo as a clear liquid. 
1H NMR (400 MHz, CDCl3) δ 4.22 (q, J = 7.2 Hz, 2H, MeCH2O), 3.37 (t, J = 7.2 Hz, 1H, H-g), 
1.95-1.86 (m, 2H, H-f), 1.45-1.25 (m, 8H, H-b to H-e), 1.29 (t, J = 7.2 Hz, 3H, MeCH2O), 0.88 












5.4. Synthesis of malonate-auxiliary adducts  
5.4.1. Amide-coupling via BtCl 
1-Chlorobenzotriazole29a (i)  
 
1H-Benzotriazole (3.00 g, 25.2 mmol) was dissolved in acetic acid (≈ 20 ml) with heating. 
Once dissolved, the contents were cooled down to rt and further cooled to 0 °C making 
sure no crystals form. Aqueous NaOCl (22.5 ml, m/v 12.5 %, 37.8 mmol, 1.5 eq) was added 
dropwise with a pressure funnel and thereafter the reaction contents allowed to stir at rt 
for 20 hrs. The yellowish precipitate that had formed, was filtered under vacuum and 
washed with cold water (500 ml), dissolved in DCM (30 ml), dried over MgSO4, filtered 
under vacuum, and concentrated under reduced pressure to obtain BtCl as off-white 
crystals (2.64 g, 68 %). 
Mp 100-102 °C (lit. 103-106); 1H NMR (300 MHz, CDCl3) δ 8.09 (d, J = 8.4 Hz, 1H, H-1), 7.62-





To a solution of PPh3 (1.55 g, 5.90 mmol, 1.3 eq) and i (0.907 g, 5.90 mmol, 1.3 eq) in MeCN 
(5.0 ml) at 0 °C was added a solution of monoacid 1a (0.600 g, 5.45 mmol, 1.2 eq) in MeCN 
(5.0 ml) slowly and the reaction contents allowed to stir at 0 °C for 30 min. The contents 
were then warmed to ambient temperature and a solution of (4S,5R)-1,5-dimethyl-4-
phenylimidazolidin-2-one (0.865 g, 4.54 mmol, 1.0 eq) in MeCN (8.0 ml) slowly added and 
the reaction contents refluxed at 85 °C overnight. After 16 hrs, the reaction mixture was 











chilled to 0 °C, diluted with KOH (15 ml, 1.0 M) and stirred for 30 min at this temperature. 
The crude residue was extracted with DCM (3 x 25 ml), the organic extracts dried over 
MgSO4, filtered under vacuum and concentrated in vacuo. The crude residue was purified 
by column chromatography (40 % EtOAc in hexanes) to afford 2a as a colourless solid (0.762 
g, 69 % yield).  
Mp 84 °C;     
  
 = –6.2, (DCM, c = 1.0); νmax (cm
-1) 3008 (Ar), 1736 (2 x C=O, amide and 
ester), 1687 (C=O, urea); 1H NMR (300 MHz, CDCl3) δ 7.35 (m, 3H, H-3’ + H-4’), 7.18 (m, 2H, 
H-2’), 5.32 (d, J = 8.7 Hz, 1H, H-1), 4.18 (q, J = 7.2 Hz, 2H, MeCH2O), 4.02 (s, 1H, H-a), 3.97 (s, 
1H, H-a), 3.93 (dq, J = 8.7, 6.6 Hz, 1H, H-2), 2.81 (s, 3H, H-4), 1.26 (t, J = 7.2 Hz, 3H, 
MeCH2O), 0.80 (d, J = 6.6 Hz, 3H, H-3); 
13C NMR (75.5 MHz, CDCl3) δ 167.7 (C=O, ester), 
165.1 (C=O, amide), 155.6 (C=O, urea), 136.1 (C-1’), 128.6 (C-3’), 128.3 (C-4’), 127.2 (C-2’), 
61.3 (MeCH2O), 59.5 (C-1), 54.2 (C-2), 43.5 (C-a), 28.3 (C-4), 15.1 (C-3), 14.2 (MeCH2O); anal. 
calc. for C16H20N2O4 (%): C, 63.14; H, 6.61; N, 9.20. Found (%): C, 63.19; H, 6.57; N, 9.24. 
5.4.2. Amide-coupling via acyl chlorides  
A representative typical procedure described below was followed to acylate (4R,5S)-1,5-




To a solution of (4R,5S)-1,5-dimethyl-4-phenylimidazolidin-2-one (1.0 g, 5.4 mmol, 1.0 eq) 
in MeCN (7.0 ml), was added slowly a solution of 1b’ (10.50 ml, 10.5 mmol, 2.0 eq, 1.0 M) in 
MeCN and the contents refluxed at 85 °C. After 4 hrs, the contents were cooled to rt, slowly 
quenched with NaHCO3 (25 ml), extracted with DCM (3 × 25 ml), the organic extracts dried 
over MgSO4, filtered under reduced pressure, and organic solvents removed under reduced 
pressure. The concentrate was purified by column chromatography (30 % EtOAc in hexane) 











diastereomeric mixture in EtOAc/ Hex to a constant Mp afforded one single diastereomer 
of 2b which was fully charaterised. 
Mp 152-153 °C;     
  
 = –31.9, (DCM, c = 1.0); νmax (cm
-1) 3010 (Ar), 1732 (2  C=O, ester 
and amide), 1689 (C=O, urea); 1H NMR (300 MHz, CDCl3) δ 7.31 (m, 3H, H-3’ + H-4’), 7.22 
(m, 2H, H-2’), 5.30 (d, J = 8.7 Hz, 1H, H-1), 4.65 (q, J = 7.5 Hz, 1H, H-b), 4.25-4.05 (m, 2H, 
MeCH2O), 3.90 (dq, J = 8.7, 6.6 Hz, 1H, H-2), 2.81 (s, 3H, H-4), 1.39 (d, J = 7.5 Hz, 3H, H-a), 
1.21 (t, J = 7.6 Hz, 3H, MeCH2O), 0.8 (d, J = 6.6 Hz, 3H, H-3); 
13C NMR (75.5 MHz, CDCl3) δ 
171.1 (C=O, ester), 169.0 (C=O, amide), 155.7 (C=O, urea), 136.2 (C-1’), 128.5 (C-3’), 128.2 
(C-4’), 127.3 (C-2’), 61.2 (MeCH2O), 59.8 (C-1), 54.3 (C-2), 45.9 (C-b), 28.4 (C-4), 15.2 (C-3), 
14.2 (MeCH2O), 13.5 (C-a); anal. cal. for C17H22N2O4 (%): C, 64.13; H, 6.97; N, 8.80. Found 
(%): C, 64.02; H, 7.04; N, 8.89. 
 
Ethyl 2-((4’S,5’R)-3’,4’-dimethyl-2’-oxo-5’-phenylimidazolidine-1’-carbonyl)butanoate (2c) 
 
Following the procedure outlined above: CA (1.0 g, 5.4 mmol, 1.0 eq) in MeCN (10 ml) was 
reacted with 1c’ (10.50 ml, 2.0 eq, 1.0 M). Chromatography (25 % EtOAc in hexane) 
afforded a mixture of diastereomers (2c, 0.757 g, 94 % yield) as off-white solid. 
Recrystallising the diastereomeric mixture of 2c in EtOAc/ Hex to a constant Mp afforded a 
single diastereomer which was fully characterised.  
Mp 126-129 °C;     
   = –4.5, (c = 1.0, DCM); νmax (cm
-1) 3010 (Ar), 1732 (2x C=O, ester and 
amide), 1689 (C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.31 (m, 3H, H-3’ + H-4’), 7.21 (m, 2H, 
H-2’), 5.31 (d, J = 8.8 Hz, 1H, H-1), 4.59 (dd, J = 5.6, 2.8 Hz 1H, H-c), 4.25-4.08 (m, 2H, 
MeCH2O), 3.91 (dq, J = 8.8, 6.8 Hz, 1H, H-2), 2.82 (s, 3H, H-4), 2.04-1.86 (m, 2H, H-b), 1.20 (t, 
J = 7.2 Hz, 3H, MeCH2O), 0.97 (t, J = 8.0 Hz, 3H, H-a), 0.80 (d, J = 6.8 Hz, 3H, H-3); 
13C (100.6 
MHz, CDCl3) δ 170.3 (C=O, ester), 168.1 (C=O, amide), 155.7 (C=O, urea), 136.2 (C-1’), 128.5 
(C-‘3), 128.2 (C-4’), 127.3 (C-2’), 61.0 (MeCH2O), 59.8 (C-1), 54.2 (C-2), 52.7 (C-c), 28.3 (C-4), 
22.1 (C-b), 15.2 (C-3), 14.2 (MeCH2O), 12.2 (C-a); anal. cal. for C18H24N2O4 (%): C, 65.04; H, 











Ethyl 2-((4’S,5’R)-3’,4’-dimethyl-2’-oxo-5’-phenylimidazolidine-1’-carbonyl)hexanoate (2d) 
 
Following the procedure outlined above: CA (1.0 g, 5.4 mmol, 1.0 eq) in MeCN (10 ml) was 
reacted with 1d’ (10.50 ml, 2.0 eq, 1.0 M). Chromatography (25 % EtOAc in hexane) 
afforded a mixture of diastereomers (2d, 0.757 g, 94 % yield) as colourless oil. 
The diastereomeric ratio of the purified product was determined to be 50 : 50 by chiral 
HPLC analysis (Chiracel OD, 95:5 hexanes: i-PrOH, 1 mL/min, λ = 254 nm, (retention 
time)major = 8.02 min, (retention time)minor = 8.12 min; νmax (cm
-1) 3010 (Ar), 1732 (2x C=O, 
ester and amide), 1689 (C=O, urea); HRMS (ES): calc. 361. 2127 for C20H29N2O4, [M + H]
+ 
requires 361.2125. 
Major diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.29 (m, 3H, H-3’ + H-4’), 7.23 (m, 1H, H-
2’), 7.12 (m, 1H, H-2’), 5.31 (d, J = 8.6 Hz, 1H, H-1), 4.63 (dd, J = 5.3, 3.4 Hz, 1H, H-e), 4.24-
4.19-4.09 (m, 2H, MeCH2O), 3.96-3.88 (m, 1H, H-2), 2.82 (s, 3H, H-4), 2.00-1.75 (m, 2H, H-d), 
1.35-1.28 (m, 2H, H-b), 1.25-1.18 (m, 2H, H-c), 1.20 (t, J = 7.2 Hz, 3H, MeCH2O), 0.82 (t, J = 
7.2 Hz, 3H, H-a), 0.80 (d, J = 6.4  Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 170.4 (C=O, 
ester), 168.4 (C=O, amide), 155.7 (C=O, urea), 136.2 (C-1’), 128.4 (C-3’), 128.2 (C-4’), 127.2 
(C-2’), 61.1 (MeCH2O), 59.7 (C-1), 54.0 (C-2), 51.1 (C-e), 29.2 (C-d), 28.3 (C-4), 27.6 (C-c), 
22.6 (C-b), 15.1 (C-3), 14.3 (MeCH2O) 14.2 (C-a). 
Minor diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.29 (m, 3H, H-3’ + H-4’), 7.23 (m, 1H, H-
2’), 7.12 (m, 1H, H-2’), 5.36 (d, J = 8.6 Hz, 1H, H-1), 4.61 (dd, J = 6.4, 1.2 Hz, 1H, H-e), 4.24-
4.19-4.09 (m, 2H, MeCH2O), 3.96-3.88 (m, 1H, H-2), 2.81 (s, 3H, H-4), 2.00-1.75 (m, 2H, H-d), 
1.35-1.28 (m, 2H, H-b), 1.25-1.18 (m, 2H, H-c), 1.26 (t, J = 7.2 Hz, 3H, MeCH2O), 0.87 (t, J = 
7.2 Hz, 3H, H-a), 0.79 (d, J = 6.4  Hz, 3H, MeCHN); 13C NMR (100.6 MHz, CDCl3) δ 170.5 (C=O, 
ester), 168.8 (C=O, amide), 155.7 (C=O, urea), 136.7 (C-1’), 128.6 (C-3’), 128.3 (C-4’), 127.3 
(C-2’), 61.1 (MeCH2O), 59.8 (C-1), 54.2 (C-2), 51.3 (C-e), 29.3 (C-d), 28.7 (C-4), 27.9 (C-c), 












Ethyl 2-((4’S,5’R)-3’,4’-dimethyl-2’-oxo-5’-phenylimidazolidine-1’-carbonyl)octanoate (2e)  
 
Following the procedure outlined above: CA (1.0 g, 5.4 mmol, 1.0 eq) in MeCN (10 ml) was 
reacted with 1e’ (10.50 ml, 2.0 eq, 1.0 M). Chromatography (25 % EtOAc in hexane) 
afforded a mixture of diastereomers (2e, 0.757 g, 94 % yield) as colourless oil. 
The diastereomeric ratio of the purified product was determined to be 51 : 49 by chiral 
HPLC analysis (Chiracel OD, 95:5 hexanes: i-PrOH, 1 mL/min, λ = 254 nm, (retention 
time)major = 7.42 min, (retention time)minor = 9.01 min; νmax (cm
-1) 3010 (Ar), 1732 (2x C=O, 
ester and amide), 1689 (C=O, urea); HRMS (ES): calc. 389.2440 for C22H33N2O4, [M + H]
+ 
requires 389.2443.  
Major diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, H-3’ + H-4’), 7.20 (m, 1H, H-
2), 7.17 (m, 1H, H-2), 5.31 (d, J = 8.8 Hz, 1H, H-1), 4.63 (dd, J = 4.6, 3.6 Hz, 1H, H-g), 4.24-
4.24-4.08 (m, 2H, MeCH2O), 3.97-3.88 (m, 1H, H-2), 2.82 (s, 3H, H-4), 1.95-1.86 (m, 2H, H-f), 
1.35-1.17 (m, 8H, H-b to H-e), 1.20 (t, J = 7.2 Hz, 3H, MeCH2O), 0.84 (t, J = 7.2 Hz, 3H, H-a), 
0.80 (d, J = 6.8  Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 170.4 (C=O, ester), 168.4 (C=O, 
amide), 155.7 (C=O, urea), 136.2 (C-1’), 128.4 (C-3’), 128.2 (C-4’), 127.2 (C-2’), 61.1 
(MeCH2O), 59.7 (C-1), 54.2 (C-2), 51.3 (C-g), 29.3 (C-e), 29.2 (C-d), 28.9 (C-f), 28.3 (C-4), 27.6 
(C-c), 22.6 (C-b), 15.1 (C-3), 14.2 (MeCH2O), 14.2 (C-a). 
Minor diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, H-3’ + H-4’), 7.17 (m, 2H, H-
2’), 5.36 (d, J = 8.4 Hz, 1H, H-1), 4.79 (dd, J = 6.0, 2.4 Hz, 1H, H-g), 4.24-4.08 (m, 2H, 
MeCH2O), 3.97-3.88 (m 1H, H-2), 2.82 (s, 3H, H-4), 1.95-1.86 (m, 2H, H-f), 1.35-1.17 (m, 8H, 
H-b to H-e), 1.25 (t, J = 7.2 Hz, 3H, MeCH2O), 0.85 (t, J = 7.2 Hz, 3H, H-a), 0.79 (d, J = 6.8  Hz, 
3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 170.5 (C=O, ester), 168.8 (C=O, amide), 155.7 (C=O, 











(C-2), 51.3 (C-g), 29.3 (C-e), 29.2 (C-d), 28.9 (C-f), 28.7 (C-4), 27.9 (C-c), 22.7 (C-b), 15.2 (C-3), 
14.2 (MeCH2O), 14.2 (C-a). 




To a solution of 1a (1.24 g, 9.46 mmol, 1.2 eq) and N,N’-dicyclohexylcarbodiimide (1.95 g, 
9.46 mmol, 1.2 eq) in DCM (8.0 ml) at 0 °C was added a solution of HOBt (0.603 g, 3.94 
mmol, 0.5 eq) in DCM (3.0 ml) followed by (4R,5S)-1,5-dimethyl-4-phenylimidazolidin-2-one 
(1.50 g, 7.88 mmol) also in DCM (3.5 ml). The contents stirred at 0 °C, slowly warmed to rt 
and left overnight. After 15 hr, the organic solvent was removed in vacuo, crude residue 
diluted with EtOAc (20 ml) and filtered through Celite under reduced pressure washing with 
EtOAc (3 x 20 ml). The organic extracts were combined, dried over MgSO4, concentrated in 
vacuo and the crude residue purified by column chromatography (40 % EtOAc in hexane) to 
afford a colourless solid (2a, 1.918 g, 80 % yield). The solid was recrystallised in EtOAc/ 
hexane and characterised as before. 
5.5. Synthesis of α-monosubstituted malonate-CA compounds 





To a solution of 2a (0.40 g, 1.31 mmol) in THF (3.5 ml) at –78 °C was added KHMDS (3.15 ml, 











Thereafter, iodomethane (0.49 ml, 3.93 mmol, 3.0 eq) was added at –78 °C and the 
contents allowed to slowly warm up to rt and left to stir overnight. After 14 hrs, the 
reaction was quenched with sat. NH4Cl/Na2S2O3 (25 ml), extracted with DCM (2 x 25 ml), 
the organic solvents combined and dried over MgSO4, filtered under pressure, and the 
organic solvent removed under reduced pressure. The concentrate purified by column 
chromatography (30 % EtOAc in hexane) to afford a mixture of diastereomers (2b, 0.375 g, 
90 % yield) as off-white solid. The product was crystallised and characterised as before.  
 
Ethyl 2-((4’S,5’R)-3’,4’-dimethyl-2’-oxo-5’-phenylimidazolidine-1’-carbonyl)butanoate (2c) 
 
Following the procedure outlined above: 2a (0.40 g, 1.31 mmol), KHMDS (3.15 ml, 1.58 
mmol, 1.2 eq) and iodoethane (0.31 ml, 3.93 mmol, 3.0 eq) were reacted in THF (3.5 ml). 
The contents were refluxed for 12 hrs. Chromatography (25 % EtOAc in hexane) afforded a 
mixture of diastereomers (2c, 0.388 g, 94 % yield) as a colourless solid. Compound 2b was 
recrystallised and characterised as before. 
 
Ethyl 2-((4’S,5’R)-3’,4’-dimethyl-2’-oxo-5’-phenylimidazolidine-1’-carbonyl)hexanoate (2d) 
 
Following the procedure outlined above: 2a (0.40 g, 1.31 mmol), KHMDS (3.15 ml, 1.58 
mmol, 1.2 eq), TBAI (0.241 g, 0.655 mmol, 0.5 eq) and 1-bromobutane (0.42 ml, 3.93 mmol, 
3.0 eq) were reacted in THF (4.5 ml). The contents were refluxed for 12 hrs. 
Chromatography (15 % EtOAc in hexane) afforded a mixture of diastereomers (2d, 0.411 g, 













Ethyl 2-((4’S,5’R)-3’,4’-dimethyl-2’-oxo-5’-phenylimidazolidine-1’-carbonyl)octanoate (2e)  
 
Following the procedure outlined above: 2a (0.40 g, 1.31 mmol), KHMDS (3.15 ml, 1.58 
mmol, 1.2 eq), TBAI (0.241 g, 0.655 mmol, 0.5 eq) and 1-bromohexane (0.72 ml, 3.93 mmol, 
3.0 eq) were reacted in THF (4.5 ml). The contents were refluxed for 12 hrs. 
Chromatography (15 % EtOAc in hexane) afforded a mixture of diastereomers (2e, 0.458 g, 





Following the above procedure: 2a (0.40 g, 1.31 mmol), KHMDS (3.15 ml, 1.58 mmol, 1.2 
eq) and 1-allyl bromide (0.44 ml, 3.93 mmol, 3.0 eq) were reacted in THF (3.0 ml). 
Chromatography (20 % EtOAc in hexane) afforded a mixture of diastereomers (3f, 0.393 g, 
87 % yield) as a colourless oil. 
νmax (cm
-1) 3010 (Ar), 2959 (alkene), 1732 (2x C=O, ester and amide), 1689 (C=O, urea); 
HRMS (ES): m/z calc. 345.1814 for C19H25N2O4, [M + H]
+ requires 345.1813. 
Major diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, H-3’ + H-4’), 7.20 (m, 1H, 
H2’), 7.17 (m, 1H, H2’), 5.81-5.45 (m, 1H, H-b), 5.35 (d, J = 8.8 Hz, 1H, H-1), 5.12-5.02 (m, 
1H, H-a), 5.01-4.92 (m, 1H, H-a), 4.91 (dd, J = 4.2, 2.6 Hz, 1H, H-d), 4.25-4.11 (m, 2H, 
MeCH2O), 3.98-3.85 (m, 1H, H-2), 2.83 (s, 3H, H-4), 2.50-2.21 (m, 2H, H-c), 1.25 (t, J = 7.2 Hz, 
3H, MeCH2O), 0.80 (d, J = 6.4 Hz, 3H, H-3); 
13C NMR (100.6 MHz, CDCl3) δ 171.6 (C=O, ester), 











127.2 (C-2’), 117.1 (C-a), 61.3 (MeCH2O), 58.8 (C-1), 54.1 (C-2), 50.9 (C-d), 32.8 (C-c), 28.3 
(C-4), 15.2 (C-3), 14.3 (MeCH2O). 
Minor diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, H-3’ + H-4’), 7.20 (m, 1H, 
H2’), 7.17 (m, 1H, H2’), 5.81-5.45 (m, 1H, H-b), 5.30 (d, J = 8.8 Hz, 1H, H-1), 5.12-5.02 (m, 
1H, H-a), 5.01-4.92 (m, 1H, H-a), 4.80 (dd, J = 5.4, 3.6 Hz, 1H, H-d), 4.25-4.11 (m, 2H, 
MeCH2O), 3.98-3.85 (m, 1H, H-2), 2.82 (s, 3H, H-4), 2.50-2.21 (m, 2H, H-c), 1.21 (t, J = 7.2 Hz, 
3H, MeCH2O), 0.80 (d, J = 6.4 Hz, 3H, H-3); 
13C NMR (100.6 MHz, CDCl3) δ 171.6 (C=O, ester), 
170.7 (C=O, amide), 155.1 (C=O, urea), 136.7 (C-1’), 135.4 (C-b), 128.6 (C-3’), 128.3 (C-4’), 
127.3 (C-2’), 117.1 (C-a), 61.3 (MeCH2O), 58.8 (C-1), 54.2 (C-2), 51.1 (C-d), 32.8 (C-c), 28.3 
(C-4), 15.2 (C-3), 14.3 (MeCH2O). 
 
5.6. Synthesis of malonate-based QSCs compounds 
A representative typical procedure described below for 2a was followed for the alkylation 





To a solution of 2b (100 mg, 0.314 mmol) in THF (1.5 ml) at –78 °C was added a solution of 
KHMDS (0.82 ml, 0.408 mmol, 1.3 eq, 0.5 M) was slowly added to the reaction contents 
allowed to stir at this temperature for 30 min. Thereafter, allyl bromide (0.10 ml, 942 mmol, 
3.0 eq) was slowly added, the reaction contents allowed to slowly warm up to rt and left to 
stir overnight for 20 hrs. The reaction was quenched with sat. NH4Cl (15 ml), extracted with 
DCM (3 x 15 ml), the organic extracts dried over MgSO4, filtered under vacuum and the 











mixture of 51 : 49 and was not purified. Instead, 3b was synthesised as a single 





Following the procedure outlined above: 2f (200 mg, 0.581 mmol), KHMDS (1.51 ml, 0.756 
mmol, 1.3 eq, 0.5 M) and iodomethane (0.12 ml, 1.743 mmol, 3.0 eq) were reacted in THF 
(1.5 ml). Chromatography (25 % EtOAc in hexane) afforded 3b as a colourless oil (172.8 mg, 
83 % yield). 
    
    = –33.3, (DCM, c = 1.0); νmax 3010 (Ar), 2991 (alkene), 1735 (2 x C=O, ester and 
amide), 1675 (C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.31 (m, 3H, H-3’ + H-4’), 7.17 (m, 2H, 
H-2’), 5.71-5.80 (m, 1H, H-b), 5.29 (d, J = 8.4 Hz, 1H, H-1), 5.04-4.98 (m, 1H, H-a),  4.97-4.89 
(m, 1H, H-a), 4.25-4.13 (m, 2H, MeCH2O), 3.90 (dq, J = 8.4, 6.4 Hz, 1H, H-2), 2.79 (s, 3H, H-4), 
2.78-2.63 (m, 2H, H-c), 1.45 (s, 3H, H-e’), 1.27 (t, J = 7.2 Hz, 3H, MeCH2O), 0.79 (d, J = 6.4 Hz, 
3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 173.1 (C=O, ester), 170.2 (C=O, amide), 155.9 (C=O, 
urea), 136.7 (C-1’), 133.8 (C-b), 128.6 (C-3’), 128.2 (C-4’), 127.0 (C-2’), 118.2 (C-a), 60.8 
(MeCH2O), 60.5 (C-1), 54.5 (C-d), 54.5 (C-2), 40.5 (C-c), 28.3 (C-4), 21.4 (C-e’), 15.1 (C-3), 
14.3 (MeCH2O); HRMS (ES): m/z calc. 359.1971 C20H27N2O4, [M + H]





Following the procedure outlined above: 2c (200 mg, 0.602 mmol), KHMDS (1.57 ml, 0.783 











(1.5 ml). Chromatography (25 % EtOAc in hexane) afforded 3c as a colourless oil (198 mg, 
95 % yield). 
    
    = –32.6, (DCM, c = 0.65); νmax 3012 (Ar), 1737 (2 x C=O, ester and amide), 1676 (C=O, 
urea); 1H NMR (400 MHz, CDCl3) δ 7.29 (m, 3H, H-3’ + H-4’), 7.16 (m, 2H, H-2’), 5.28 (d, J = 
8.4 Hz, 1H, H-1), 4.25-4.11 (m, 2H, MeCH2O), 3.89 (dq, J = 8.4, 6.4 Hz, 1H, H-1), 2.76 (s, 3H, 
H-4), 2.02-1.90 (m, 2H, H-b), 1.42 (s, 3H, H-d’), 1.25 (t, J = 7.2 Hz, 3H, MeCH2O), 0.82 (t, J = 
7.2 Hz, 3H, H-a), 0.76 (d, J = 6.4 Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 172.9 (C=O, 
ester), 170.8 (C=O, amide), 155.4 (C=O, urea), 136.9 (C-1’), 128.6 (C-3’), 128.2 (C-4’), 127.1 
(C-2’), 60.6 (MeCH2O), 60.5 (C-1), 55.5 (C-c), 54.4 (C-2), 29.0 (C-b), 28.3 (C-4), 21.0 (C-d’), 







Following the procedure outlined above: 2c (200 mg, 0.602 mmol), KHMDS (1.57 ml, 0.783 
mmol, 1.3 eq, 0.5 M) and allyl iodide (0.17 ml, 1.806 mmol, 3.0 eq) were reacted in THF (1.5 
ml). Chromatography (25 % EtOAc in hexane) afforded 3d as a colourless oil (203 mg, 92 % 
yield). 
The diastereomeric ratio of the purified product was determined to be 95 : 5 by chiral HPLC 
analysis (Chiracel OD, 95 : 5 hexanes : i-PrOH, 1 mL/min, λ = 254 nm, (retention time)major = 
8.23 min, (retention time)minor = 9.56 min;     
    = –23.6, (DCM, c = 1.0); νmax 3010 (Ar), 
2987 (alkene), 1737 (2 x C=O, ester and amide), 1675 (C=O, urea); 1H NMR (400 MHz, CDCl3) 
δ 7.30 (m, 3H, H-3’ + H-4’), 7.19 (m, 2H, H-2’), 5.49-5.37 (m, 1H, H-e’), 5.32 (d, J = 8.4 Hz, 1H, 
H-1), 5.00-4.94 (m, 1H, H-f’), 4.91-4.85 (m, 1H, H-f’), 4.25-4.11 (m, 2H, MeCH2O), 3.91 (dq, J 
= 8.4, 6.4 Hz, H-2), 2.93-2.85 (m, 1H, H-d’), 2.78 (s, 3H, H-4), 2.74-2.68 (m, 1H, H-d’), 2.00 (q, 











7.6 Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 171.5 (C=O, ester), 169.8 (C=O, amide), 
155.3 (C=O, urea), 136.7 (C-1’), 133.3 (C-e’), 128.5 (C-3’), 128.2 (C-4’), 127.3 (C-2’), 118.0 (C-
f’), 60.6 (MeCH2O), 60.5 (C-1), 58.8 (C-c), 54.4 (C-2), 37.5 (C-d’), 28.3 (C-4), 26.0 (C-b), 15.1 







Following the procedure outlined above: 2c (200 mg, 0.602 mmol), KHMDS (1.57 ml, 0.783 
mmol, 1.3 eq, 0.5 M) and benzyl bromide (0.21 ml, 1.806 mmol, 3.0 eq) were reacted in THF 
(1.5 ml). Chromatography (25 % EtOAc in hexane) afforded 3e as a colourless solid (219 mg, 
89 % yield). Compound 3e was recrystallised to a constant Mp and characterised. 
Mp 107-110 °C;     
    = –42.0, (DCM, c = 0.8); νmax (cm
-1) 3008 (Ar), 2998 (Bn), 1739 (2 x 
C=O, ester and amide), 1635 (C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.37 (m, 3H, H-3’ + H-
4’), 7.25 (m, 2H, H-2’), 7.07 (m, 1H, H-4”), 6.98 (m, 2H, H-3”), 6.84 (m, 2H, H-2”), 5.37 (d, J = 
8.5 Hz, 1H, H-1), 4.04 (q, J = 9.6 Hz, 2H, MeCH2O), 3.95 (dq, J = 8.5, 6.6 Hz, 1H, H-2), 3.37 (bs, 
2H, H-d’), 2.81 (s, 3H, H-4), 1.98-1.89 (m, 2H, H-b), 1.12 (t, J = 9.6 Hz, 3H, MeCH2O), 0.87 (t, J 
= 7.5 Hz, 3H, H-a), 0.86 (d, J = 6.6 Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 171.5 (C=O, 
ester), 169.9 (C=O, amide), 155.6 (C=O, urea), 137.12 (C-1), 136.7 (C-1”), 130.7 (C-2”), 128.6 
(C-3’), 128.2 (C-4’), 128.0 (C-2’), 127.8 (C-3”), 126.41 (C-4”), 61.0 (MeCH2O), 60.5 (C-1), 55.4 
(C-c), 54.7 (C-2), 39.5 (C-d’), 28.36 (C-4), 26.65 (C-b), 15.1 (C-3), 14.1 (MeCH2O), 9.1 (C-a); 
















methylhexanoate (3f)  
 
Following the procedure outlined above: 2d (200 mg, 0.555 mmol), KHMDS (1.44 ml, 0.721 
mmol, 1.3 eq, 0.5 M) and iodomethane (0.10 ml, 1.665 mmol, 3.0 eq) were reacted in THF 
(1.5 ml). Chromatography (20 % EtOAc in hexane) afforded 3f as a colourless oil (283 mg, 88 
% yield).  
The diastereomeric ratio of the purified product was determined to be 97 : 3 by chiral HPLC 
analysis (Chiracel OD, 95 : 5 hexanes : i-PrOH, 1 mL/min, λ = 254 nm, (retention time)major = 
7.12 min, (retention time)minor = 8.01 min;     
    = –40.5, (DCM, c = 1.0); νmax (cm
-1) 3010 
(Ar), 1739 (2 x C=O, ester and amide), 1677 (C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.30 
(m, 3H, H-3’ + H-4’), 7.17 (m, 2H, H-2’), 5.30 (d, J = 8.4 Hz, 1H, H-1), 4.20 (m, 2H, MeCH2O), 
3.91 (dq, J = 8.4, 6.4 Hz, 1H, H-2), 2.78 (s, 3H, H-4), 1.92 (m, 2H, H-d), 1.45 (s, 3H, H-f’), 1.37-
1.80 (m, 3H, 1H-c + H-b), 1.27 (t, J = 6.8 Hz, 3H, MeCH2O), 1.10-1.00 (m, 1H, 1H-c), 0.86 (t, J 
= 7.2 Hz, 3H, H-a), 0.78 (d, J = 6.4 Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 173.1 (C=O, 
ester), 170.9 (C=O, amide), 155.3 (C=O, urea), 136.8 (C-1’), 128.6 (C-3’), 128.2 (C-4’), 127.0 
(C-2’), 60.7 (MeCH2O), 60.5 (C-1), 55.0 (C-e), 54.4 (C-2), 35.8 (C-d), 28.3 (C-4), 26.7 (C-c), 
23.2 (C-b), 21.6 (C-f’), 15.1 (C-3), 14.3 (MeCH2O), 14.1 (C-a). HRMS (ES): m/z calc. 375.2284 
C21H31N2O4, [M + H]















Following the procedure outlined above: 2d (200 mg, 0.555 mmol), KHMDS (1.44 ml, 0.721 
mmol, 1.3 eq, 0.5 M) and allyl iodide (0.15 ml, 1.665 mmol, 3.0 eq) were reacted in THF (1.5 
ml). Chromatography (20 % EtOAc in hexane) afforded 3g as a colourless solid (189 mg, 85 
% yield). Compound 3g was recrystallised to a constant Mp and characterised. 
Mp 88-90 °C;     
    = 30.2, (DCM, c = 0.8); νmax (cm
-1) 3009 (Ar), 2989 (alkene), 1738 (2 x 
C=O, ester and amide), 1674 (C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, H-3’ + H-
4’), 7.20 (m, 2H, H-2’), 5.49-5.40 (m, 1H, H-g’), 5.31 (d, J = 8.4 Hz, 1H, H-1), 5.00-4.95 (m, 1H, 
H-h’), 4.90-4.87 (m, 1H, H-h’), 4.25-4.09 (m, 2H, MeCH2O), 3.91 (dq, J = 8.4, 6.4 Hz, 1H, H-2), 
2.90-2.89 (m, 1H, H-f’), 2.79 (s, 3H, H-4), 2.75-2.69 (m, 1H, H-f’), 2.00-1.92 (m, 2H, H-d), 
1.35-1.19 (m, 3H, H-b + 1H-c), 1.26 (t, J = 7.2 Hz, 3H, MeCH2O), 1.08-0.98 (m, 1H, 1H-c), 0.86 
(t, J = 7.2 Hz, 3H, H-a), 0.79 (d, J = 6.4 Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 171.6 
(C=O, ester), 170.0 (C=O, amide), 155.3 (C=O, urea), 136.7 (C-1’), 133.4 (C-g’), 128.5 (C-3’), 
128.2 (C-4’), 127.3 (C-2’), 118.0 (C-h’), 60.6 (MeCH2O), 60.5 (C-1), 58.4 (C-e), 54.4 (C-1), 38.1 
(C-f’), 32.8 (C-d), 28.3 (C-4), 26.3 (C-c), 23.1 (C-b), 15.1 (C-3), 14.4 (MeCH2O), 14.1 (C-a); 





Following the procedure outlined above: 2d (200 mg, 0.555 mmol), KHMDS (1.44 ml, 0.721 
mmol, 1.3 eq, 0.5 M) and benzyl bromide (0.20 ml, 1.665 mmol, 3.0 eq) were reacted in THF 
(1.5 ml). Chromatography (20 % EtOAc in hexane) afforded 3h as a colourless oil (163 mg, 
84 % yield).  
The diastereomeric ratio of the purified product was determined to be 99 : 1 by chiral HPLC 
analysis (Chiracel OD, 95 : 5 hexanes : i-PrOH, 1 mL/min, λ = 254 nm, (retention time)major = 
7.58 min, (retention time)minor = 8.31 min;     
    = –10.7, (DCM, c = 2.3); νmax (cm
-1) 3111 











CDCl3) δ 7.34 (m, 3H, H-3’ + H-4’), 7.26 (m, 2H, H-2’), 7.07 (m, 1H, H-4”), 6.99 (m, 2H, H-3”), 
6.82 (m, 2H, H-2”), 5.36 (d, J = 8.4 Hz, 1H, H-1), 4.04 (q, J = 7.2 Hz, 2H, MeCH2O), 3.95 (dq, J 
= 8.4, 6.8 Hz, 1H, H-2), 3.38 (bs, 2H, H-f’), 2.81 (s, 3H, H-4), 1.87-1.77 (m, 2H, H-d), 1.42-1.30 
(m, 1H, 1H-c), 1.29-1.20 (m, 2H, H-b), 1.12 (t, J = 7.2 Hz, 3H, MeCH2O), 1.10-1.05 (m, 1H, 1H-
c), 0.87 (t, J = 6.8 Hz, 3H, H-a), 0.85 (d, J = 7.2 Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 
171.6 (C=O, ester), 170.1 (C=O, amide), 155.5 (C=O, urea), 137.0 (C-1), 136.6 (C-1”), 130.6 
(C-2”), 128.5 (C-3’), 128.2 (C-4’), 127.8 (C-2’ + C-3”), 126.4 (C-4”), 60.8 (MeCH2O), 60.5 (C-1), 
59.9 (C-e), 54.5 (C-2), 39.7 (C-f’), 33.1 (C-d), 28.4 (C-4), 26.7 (C-c), 23.1 (C-b), 15.1 (C-3), 14.1 
(MeCH2O), 14.1 (C-a); HRMS (ES): m/z calc. 451.2590 C27H35N2O4, [M + H]






Following the procedure outlined above: 2e (200 mg, 0.515 mmol), KHMDS (1.34 ml, 0.669 
mmol, 1.3 eq, 0.5 M) and iodomethane (0.10 ml, 1.544 mmol, 3.0 eq) were reacted in THF 
(1.5 ml). Chromatography (15 % EtOAc in hexane) afforded 3i as a colourless oil (187 mg, 90 
% yield).  
    
    = –47.0, (DCM, c = 1.0); νmax (cm
-1) 3011 (Ar), 1735 (2 x C=O, ester and amide), 1675 
(C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, H-3’ + H-4’), 7.17 (m, 2H, H-2’), 5.29 
(d, J = 8.4 Hz, 1H, H-1), 4.26-4.12 (m, 2H, MeCH2O), 3.90 (dq, J = 8.4, 6.4 Hz, 1H, H-2), 2.78 
(s, 3H, H-4), 1.98-1.85 (m, 2H, H-f), 1.45 (s, 3H, H-h’), 1.38-1.31 (m, 1H, 1H-e), 1.27 (t, J = 7.2 
Hz, 3H, MeCH2O), 1.26-1.22 (m, 6H, H-b to H-d), 1.13-0.98 (m, 1H, 1H-e), 0.85 (t, J = 6.8 Hz, 
3H, H-a), 0.78 (d, J = 6.4 Hz, 3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 173.1 (C=O, ester), 
170.9 (C=O, amide), 155.3 (C=O, urea), 136.8 (C-1’), 128.6 (C-3’), 128.2 (C-4’), 127.0 (C-2’), 











24,4 (C-e), 22.7 (C-b), 21.6 (C-h’), 15.1 (C-3), 14.3 (MeCH2O), 14.2 (C-a); HRMS (ES): m/z calc. 
403.2587 C23H35N2O4, [M + H]





Following the procedure outlined above: 2e (200 mg, 0.515 mmol), KHMDS (1.34 ml, 0.669 
mmol, 1.3 eq, 0.5 M) and allyl iodide (0.14 ml, 1.544 mmol, 3.0 eq) were reacted in THF (1.5 
ml). Chromatography (15 % EtOAc in hexane) afforded 3j as a colourless oil (192 mg, 87 % 
yield).  
The diastereomeric ratio of the purified product was determined to be > 99 : 1 by chiral 
HPLC analysis (Chiracel OD, 95 : 5 hexanes : i-PrOH, 1 mL/min, λ = 254 nm, (retention 
time)major = 11.21 min, (retention time)min r = 11.56 min;     
    = –27.2, (DCM, c = 1.0); νmax 
(cm-1) 3010 (Ar), 2988 (alkene), 1735 (2 x C=O, ester and amide), 1674 (C=O, urea); 1H NMR 
(400 MHz, CDCl3) δ 7.30 (m, 3H, H-3’ + H-4’), 7.18 (m, 2H, H-2’), 5.50-5.41 (m, 1H, H-i’), 5.31 
(d, J = 8.4 Hz, 1H, H-1), 5.00-4.96 (m, 1H, H-j’), 4.91-4.87 (m, 1H, H-j’), 4.24-4.11 (m, 2H, 
MeCH2O), 3.91 (dq, J = 8.4, 6.4 Hz, 1H, H-2), 2.96-2.88 (m, 1H, H-h’), 2.79 (s, 3H, H-4), 2.76-
2.69 (m, 1H, H-h’), 1.97-1.88 (m, 2H, H-f), 1.28-1.22 (m, 7H, H-b to H-d + 1H-e), 1.26 (t, J = 
7.2 Hz, 3H, MeCH2O), 1.19-1.00 (m, 1H, 1H-e), 0.85 (t, J = 6.8 Hz, 3H, H-a), 0.80 (d, J = 6.4 Hz, 
3H, H-3); 13C NMR (100.6 MHz, CDCl3) δ 171.6 (C=O, ester), 170.0 (C=O, amide), 155.3 (C=O, 
urea), 136.7 (C-1’), 133.4 (C-i’), 128.5 (C-3’), 128.2 (C-4’), 127.3 (C-2’), 118.0 (C-j’), 60.6 
(MeCH2O), 60.5 (C-1), 58.4 (C-g), 54.4 (C-2), 38.1 (C-h’), 33.0 (C-f), 31.7 (C-d), 29.6 (C-c), 28.3 
(C-4), 24.0 (C-e), 22.7 (C-b), 15.1 (C-3), 14.4 (MeCH2O), 14.2 (C-a). HRMS (ES): m/z calc. 
429.2753 C25H37N2O4, [M + H]
















Following the procedure outlined above: 2e (200 mg, 0.515 mmol), KHMDS (1.34 ml, 0.669 
mmol, 1.3 eq, 0.5 M) and benzyl bromide (0.18 ml, 1.544 mmol, 3.0 eq) were reacted in THF 
(1.5 ml). Chromatography (15 % EtOAc in hexane) afforded 3k as a colourless oil (202 mg, 
82 % yield).  
The diastereomeric ratio of the purified product was determined to be > 99 : 1 by chiral 
HPLC analysis (Chiracel OD, 95 : 5 hexanes : i-PrOH, 1 mL/min, λ = 254 nm, (retention 
time)major = 11.45 min, (retention time)minor = 12.36 min;     
    = 3.2, (DCM, c = 2.1); νmax 
(cm-1) 3013 (Ar), 1739 (2 x C=O, ester and amide), 1677 (C=O, urea); 1H NMR (400 MHz, 
CDCl3) δ 7.34 (m, 3H, H-3’ + H-4’), 7.26 (m, 2H, H-2’), 7.07 (m, 1H, H-4”), 6.99 (m, 2H, H-3”), 
6.82 (m, 2H, H-2”), 5.36 (d, J = 8.4 Hz, 1H, H-1), 4.04 (q, J = 7.2 Hz, 2H, MeCH2O), 3.94 (dq, J 
= 8.4, 6.6 Hz, 1H, H-1), 3.38 (bs, 2H, H-h’), 2.81 (s, 3H, H-4), 1.90-1.80 (m, 2H, H-f), 1.42-1.35 
(m, 1H, H-e), 1.30-1.20 (m, 6H, H-b to H-d), 1.11 (t, J = 7.2 Hz, 3H, MeCH2O), 1.16-1.08 (m, 
1H, 1H-e), 0.86 (d, J = 6.6 Hz, 3H, H-3), 0.85 (t, J = 6.8 Hz, 3H, H-a); 13C NMR (100.6 MHz, 
CDCl3) δ 171.6 (C=O, ester), 170.0 (C=O, amide), 155.5 (C=O, urea), 137.0 (C-1’), 136.6 (C-
1”), 130.6 (C-2”), 128.5 (C-3’), 128.2 (C-4’), 127.8 (C-2’ + C-3”), 126.4 (C-4”), 60.8 (MeCH2O), 
60.5 (C-1), 60.0 (C-g), 54.5 (C-2), 39.7 (C-h’), 33.2 (C-f), 31.8 (C-d), 29.6 (C-c), 28.4 (C-4), 24.4 
(C-e), 22.7 (C-b), 15.1 (C-3), 14.2 (MeCH2O), 14.1 (C-a). HRMS (ES): m/z calc. 479.2910 
C29H39N2O4, [M + H]
+ requires 479.2916. 
 
5.7. The CA cleavage via thioester synthesis  
A representative typical procedure described below was followed for CA cleavage via the 













(2S)-Ethyl 2-benzyl-2-((ethylthio)carbonyl)butanoate (4a) 
  
To a suspension of ethanethiol (0.18 ml, 2.49 mmol, 10.5 eq) in THF (2.0 ml) at –78 °C was 
slowly added n-BuLi (0.94 ml, 2.37 mmol, 10 eq, 2.5 M). After 30 min, a solution of 3e (100 
mg, 0.237 mmol) in THF (1.5 ml) was slowly added to the reaction mixture at –78 °C and the 
contents allowed to gradually warm up to rt over 1 hr. Thereafter, the reaction mixture was 
warmed to 40 °C and stirred at this temperature for 5 hrs. The contents were cooled to rt 
and quenched with sat. NaHCO3 (15 ml), extracted with DCM (3 x 20 ml), the organic 
extracts combined and dried over MgSO4. Following the removal of organic solvent under 
reduced pressure, the crude residue was purified by column chromatography using (5 % 
EtOAc in hexane) to afford 4a as a yellowish liquid (60 mg, 82 %). 
    
    = –17.5, (DCM, c = 1.2); vmax (cm
-1) = 3109 (Ar), 2999 (Bn), 1742 (C=O, ester), 1691 
(C=O, thioester); 1H NMR (400 MHz, CDCl3) δ 7.22 (m, 3H, H-3” + H-4”), 7.10 (m, 2H, H-2”), 
4.27-4.13 (m, 2H, MeCH2O), 3.33 (d, J = 14.4 Hz, 1H, H-d’), 3.27 (d, J = 14.4 Hz, 1H, H-d’), 
2.92 (q, J = 7.2 Hz, 2H, MeCH2S), 1.95-1.87 (m, 2H, H-b), 1.26 (t, J = 7.2 Hz, 3H, MeCH2O), 
1.26 (t, J = 7.2 Hz, 3H, MeCH2S), 0.94 (t, J = 7.2 Hz, 3H, H-a); 
13C NMR δ (101 MHz, CDCl3) 
199.2 (C=O, thioester), 171.1 (C=O, ester), 136.2 (C-1”), 130.1 (C-2”), 128.3 (C-3”), 127.0 (C-
4”), 66.4 (C-c), 61.6 (MeCH2O), 37.5 (C-d’), 24.9 (C-b), 23.7 (MeCH2S), 14.6 (MeCH2O), 14.1 
(MeCH2S), 8.51 (C-a); HRMS (ES): m/z calc. 295.1363 C16H23O3S, [M + H]
+ requires 295.1370. 
 
(2R)-Ethyl 2-((ethylthio)carbonyl)-2-methylhexanoate (4b) 
  
Following the procedure outlined above, ethane thiol (0.20 ml, 2.804 mmol, 10.5 eq), n-BuLi 











After 2 hrs at 40 °C the reaction was complete. The crude was purified by column 
chromatography using (5 % EtOAc in hexane) to obtain 4b as a clear liquid (53 mg, 77 %).   
    
    = –1.5, (DCM, c = 1.2); vmax (cm
-1) 1740 (C=O, ester), 1689 (C=O, thioester); 1H NMR 
(400 MHz, CDCl3) δ 4.18 (q, J = 7.2 Hz, 2H, MeCH2O), 2.88 (q, J = 7.2 Hz, 2H, MeCH2S), 2.00-
1.79 (m, 2H, H-d), 1.44 (s, 3H, H-f), 1.36-1.28 (m, 2H, H-b), 1.25 (t, J = 7.2 Hz, 3H, MeCH2O), 
1.24 (t, J = 7.2 Hz, 3H, MeCH2S), 1.27-1.12 (m, 2H, H-c), 0.90 (t, J = 6.8 Hz, H-a); 
13C NMR 
(101 MHz, CDCl3) δ 200.0 (C=O, thioester), 172.1 (C=O, ester), 61.5 (MeCH2O), 61.2 (C-e), 
35.8 (C-d), 26.5 (C-c), 23.6 (MeCH2S), 23.2 (C-b), 20.0 (C-f’), 14.6 (MeCH2O), 14.1 (MeCH2S), 
14.0 (C-a). 
 
(2S)-Ethyl 2-allyl-2-((ethylthio)carbonyl)octanoate (4c) 
 
Following the procedure outlined above: ethanethiol (0.18 ml, 2.450 mmol, 10.5 eq) n-BuLi 
(0.93 ml, 2.33 mmol, 2.5 M, 10.0 eq) 3i (100 mg, 0.233 mmol) were used. After 4 hrs at 40 
°C the reaction was found to be complete. The crude mixture was purified by column 
chromatography using (5 % EtOAc in hexane) to obtain 4c as a brownish liquid (66 mg, 89 
%).   
    
    = –5.9, (DCM, c = 1.2); vmax (cm
-1) 2985 (alkene), 1741 (C=O, ester), 1689 (C=O, 
thioester); 1H NMR (400 MHz, CDCl3) δ 5.65-5.57 (m, 1H, H-i’), 5.12-5.04 (m, 2H, H-j’), 4.18 
(q, J = 7.2 Hz, 2H, MeCH2O), 2.90 (q, J = 7.2 Hz, 2H, MeCH2S), 2.72-2.70 (m, 2H, H-h’), 1.93 
(m, 2H, H-f), 1.30-1.21 (m, 7H, H-b + 1H-c to H-e), 1.25 (t, J = 7.2 Hz, 3H, MeCH2O), 1.24 (t, J 
= 7.2 Hz, 3H, MeCH2S), 1.18-1.09 (m, 1H, 1H-c), 0.87 (t, J = 6.8 Hz, 3H, H-a); 
13C NMR (101 
MHz, CDCl3) δ 199.9 (C=O, thioester), 171.1 (C=O, ester), 132.4 (C-i'), 119.1 (C-j’), 64.7 (C-g’), 
61.5 (MeCH2O), 36.9 (C-h’), 32.3 (C-f), 31.6 (C-e), 29.6 (C-d), 23.6 (C-c), 23.6 (MeCH2S), 22.7 











5.8. Reduction via a Fukuyama protocol 
(2S)-Ethyl 2-benzyl-2-(hydroxymethyl)butanoate (6a) 
 
A reaction flask with Pd/C (5.4 mg, 0.051 mmol, 0.30 eq) was purged with argon for 10 min 
and dry THF (1.0 ml) added. To this suspension was slowly added a solution of 4a (50 mg, 
0.170 mmol) in THF (1.5 ml) followed by triethylsilane (0.09 ml, 0.509 mmol, 3.0 eq) and the 
contents allowed to stir at rt. After 2 hrs, the contents were diluted with EtOAc (10 ml), 
filtered through Celite under reduced pressure, washed with EtOAc (2 x 20 ml) and the 
organic extracts concentrated in vacuo. Aldehyde 5a was pure enough by 1H NMR 
spectroscopy to be used without further purification in the next step. 
NaBH4 (32 mg, 0.85 mmol, 5.0 eq) was suspended in dry THF (1.0 ml) at 0 °C under nitrogen. 
To this solution was slowly added the crude mixture of 5a (40 mg, 0.170 mmol) in THF (1.5 
ml) at the same temperature. After 2 hrs the reaction mixture was slowly quenched with 
HCl (1.0 M, 10 ml), extracted with DCM (3 x 15 ml), the organic extracts dried over MgSO4, 
which were filtered under reduced pressure and concentrated in vacuo. The crude residue 
was purified by column chromatography (20 % EtOAc in hexane) to afford the alcohol (6a, 
26 mg, 66 % over two steps) as a clear oil. 
    
    = –21.9, (DCM, c = 0.9); vmax (cm
-1) 3339 (OH), 3112 (Ar), 3002 (Bn), 1730 (C=O, ester); 
1H NMR (400 MHz, CDCl3) δ 7.23 (m, 5H, Ph), 4.24-4.12 (m, 2H, MeCH2O), 3.71 (d, J = 11.2 
Hz, 1H, CH2OH), 3.51 (d, J = 11.2 Hz, 1H, CH2OH), 3.08 (d, J = 13.4 Hz, 1H, H-d’), 2.86 (d, J = 
13.4 Hz, 1H, H-d’), 2.15 (bs, 1H, OH), 1.75-1.65 (m, 1H, H-b), 1.51-1.42 (m, 1H, H-b), 1.27 (t, J 
= 7.2 Hz, 3H, MeCH2O), 0.91 (t, J = 7.2 Hz, 3H, H-a); 
13C NMR (101 MHz, CDCl3) δ 176.3 (C=O, 
ester), 137.2 (C-1), 130.5 (C-2), 128.3 (C-3), 126.7 (C-4), 63.6 (CH2OH), 60.7 (MeCH2O), 52.6 














(2R)-Ethyl 2-(hydroxymethyl)-2-methylhexanoate (6b) 
 
Thioester 4b (50 mg, 0.202 mmol) was subjected to the same conditions as 4a, where Pd/C 
(5.4 mg, 0.051 mmol, 0.30 eq); 4b (50 mg, 0.170 mmol); triethylsilane (0.09 ml, 0.509 mmol, 
3.0 eq) were used to afford aldehyde 5b which was subsequently used in the next reaction 
withouth further purification. The aldehyde 5b (38 mg, 0.202 mmol) was reduced as before 
with NaBH4 (39 mg, 1.015 mmol, 5.0 eq) to afford alcohol 6b (21 mg, 55 % over two steps) 
as a clear oil.  
    
    = –2.6, (DCM, c = 1.3); vmax (cm
-1) 3337 (OH), 1732 (C=O, ester); 1H NMR (400 MHz, 
CDCl3) δ 4.17 (q, J = 7.2 Hz, 2H, MeCH2O), 3.71 (d, J = 11.2 Hz, 1H, CH2OH), 3.47 (d, J = 11.2 
Hz, 1H, CH2OH), 2.16 (bs, 1H, OH), 1.65-1.51 (m, 2H, H-d), 1.27 (t, J = 7.2 Hz, 3H, MeCH2O), 
1.29-1.18 (m, 4H, H-b + H-c), 1.17 (s, 3H, H-f’), 0.89 (t, J = 7.2 Hz, 3H, H-a); 13C NMR (101 
MHz, CDCl3) δ 177.4 (C=O, ester), 68.5 (CH2OH), 60.7 (MeCH2O), 47.8 (C-e), 35.8 (C-d), 26.5 
(C-c), 23.3 (C-b), 19.8 (C-f’), 14.4 (MeCH2O), 14.0 (C-a); HRMS (ES): m/z calc 189.1491 
C10H21O3, [M + H]
+ requires 189.1496. 
 
Subjecting thioester 4c to the Fukuyama reduction conditions resulted in the reduction 




















Part 3: University of Michigan Research 
Chapter 6: Introduction to Lactimidomycin 
6.1. Cancer 
Cancer is a class of diseases characterised by the uncontrolled growth of abnormal cells 
that are capable of migrating from one part of the body to another.39 Such a migration is 
known as metastasis. Under normal circumstances, a defective or abnormal cell that is 
‘beyond-repair,’ is killed so as to avoid replicating its defective material (during cell division) 
by a process known as “programmed cell-death” or simply “apoptosis”. However, 
cancerous cells are able to survive and reproduce other cancerous cells because of their 
ability to elude apoptosis. Cancer is a worldwide challenge that claims millions of lives 
annually and accounted for 7.6 million deaths in 2008.40 
Over the past century various chemotherapeutic drugs have been developed and used with 
success to combat different types of cancer.41 In particular, natural compounds have been 
used with great success in the fight against cancer. Examples of natural compounds or 
derivatives thereof on the market include paclitaxel from the bark of the pacific yew tree, 
camptothecin derivatives from camptotheca acuminata plant, daunorubicin from 
Streptomyces peucetius to mention a few.41  
 
Figure 6.1: Anti-cancer drugs derived from Nature. 
6.2. Biosynthesis of the GcP family  
A family of glutarimide-containing polyketide (GcP) compounds isolated from Streptomyces 











fungal activity.42 Some of the compounds known to date from this family include 
lactimidomycin (a), iso-migrastatin (b), migrastatin (c), dorrigocin A (d), and dorrigocin B (e), 
Figure 6.2. Lactimidomycin was isolated in 1992,42a followed by dorrigocin A and B in 
1994.42c Six years later Imoto et al reported the isolation and characterisation of 
migrastatin,42d and thereafter Licari et al reported iso-migrastatin in 2002.42e 
 
Figure 6.2:  Compounds from the GcP family known to date.  
 
Compounds from this family a e characterised by the presence of a glutarimide moiety in 
the side chain, together with an unsaturated cyclic macrolide core (12- or 14-membered 
ring) or its acyclic version.42b In his biosynthesis studies, Shen suggested that (b) is the 
parent natural compound from this family, while the other compounds are shunt 
metabolites (derivatives).43 The biological properties as well as the structural relatedness of 
these compounds has captured great interest in studying this family of compounds as one 
can potentially synthesise the natural compounds including their analogues by a few 
transformations from a core intermediate.  
6.3. The GcP family as potential anti-metastasis agents 
Conventional cancer chemotherapy relies on the cytotoxicity of the therapeutic agent even 











lesion of cancerous cells.44 However, in recent years there has been a shift to address the 
issue of metastasis, and the GcP compounds have immerged as potential drug leads as anti-
metastasis agents. Sugawara et al has demonstrated that lactimidomycin exhibits the 
inhibition of fungal growth and prolongs the survival time of mice with P388 leukaemia.42a 
Also, in vitro studies by Shen et al indicate that lactimidomycin is a strong migration 
inhibitor of human MDA-MB-231 (IC50 = 0.6 nM) and mouse 4T1 (IC50 = 5.03 nM) mammary 
adenocarcinoma cell lines.45 In addition, lactimidomycin is a strong inhibitor of eukaryotic 
translation elongation (IC50 = 38 nM), and has a potent antiproliferative effect on tumour 
cell-lines in vivo.45  
The current research was inspired by Shen’s45 report (2009) that claimed lactimidomycin as 
one of the most potential anti-metastasis agents, although a recent report by Fürstner46 
(2013) questions the integrity of lactimidomycin as a potential anti-metastasis agent. Thus 
far, the total synthesis of lactimidomycin has been achieved by Fürstner,47 Nagorny48 and 
Kuwahara,49 and it is hoped that such research may shed some light on the verification of 
lactimidomycin’s biological activity. Also, Danishefsky has reported the total synthesis of 
migrastatin and its analogues. 50 
6.4. Aims and Objectives 
In view of the biological evidence before Fürstner’s 2013 report and before any total 
synthesis of lactimidomycin had been reported, the Nagorny group sought to design a 
versatile total synthesis to lactimidomycin such that a rapid synthesis of its analogues could 
be achieved for biological evaluation. When I joined the Nagorny group in late 2011, the 
objective was to design a versatile route for analogue synthesis, with the first target 
analogue being the truncated macrolide 10, Figure 6.3. The interest in the macrolide ring 
moiety as opposed to the polyketide glutarimide moiety was inspired by Danishefsky’s 
studies on migrastatin (c) which revealed that its truncated 14-membered macrolide was 












Figure 6.3: Lactimidomycin and its macrolide analogue (10). 
6.5. Retrosynthetic Analysis of 10 
There are three important structural sites in macrolide 10, which are the anti-relationship 
between C-11 and C-12, the (E,Z)-diene, and the trans-enone. It was thought that the anti-
stereochemistry could be synthesised via the Evans’ chiral auxiliary (CA) mediated aldol 
reaction. The (E,Z)-diene moiety was envisaged as constructible via a cross-coupling 
method, while the lactenone should be accessed via an intramolecular Horner-Wadsworth-
Emmons (HWE) olefination reaction that would simultaneously cyclise to the macrolide.   
Based on these ideas a retrosynthetic analysis identified 10 being disconnected to aldehyde 
9, the HWE precursor, which in turn disconnects to 6’ via a stereoselective reduction using 
Lindlar’s catalyst to obtain the (E,Z)-diene, Scheme 6.2. Of note was that a chemoselective 
deprotection of the TES-PG followed by acylation with iii needed to be done once 6’ had 
been reduced to the (E,Z)-diene. Compound 6’ disconnects via Sonogashira cross-coupling 
to alkyne 5’ involving a TBPS-protected trans-vinyl iodide (ii). Alkyne 5’ was to be accessed 
via the Ohira-Bestmann homologation of i and aldehyde 4 which in turn is a product of 
Evans’ CA cleavage via thioester 3. Compound 3 can be accessed from an Evans’ mediated 







































Chapter 7: Results and Discussion 
7.1. Route 1: synthesis of macrolide 10 via the Ohira-Bestmann homologation  
Synthesis towards macrolide 10 commenced with a facile acylation of (R)-4-
benzyloxazolidin-2-one with propionyl chloride to afford 1 (91 % yield) a known compound, 
whose spectroscopic characteristics corresponded with literature data.9b, 51 To install the 
anti-stereochemistry in 10, an Evans’ aldol reaction between 1 and freshly distilled 
acetaldehyde was utilised to obtain 2a (75 % yield) as a colourless solid.9b, 51 Evans’ CA-
mediated boron-enolate aldol addition reactions are known to go via the well-known 
chelated Zimmerman-Traxler TS-model (discussed in Chapter 1) to give the Evans syn-aldol 
adduct 2a, Scheme 7.1.14 The anti-aldol adduct was undetectable by both 1H NMR and 13C 
NMR spectroscopy. Compound 2a was subsequently protected with a TES-protecting group 
(PG) to obtain 2b (94 % yield) as a colourless oil, whose data corresponded with the 
literature. A TES-PG was chosen because it could be chemosectively removed in the 
presence of a TBDPS-PG.  
 
Scheme 7.1: Reaction Conditions- a) n-BuLi, propionyl chloride, THF, –78 °C. b) 1, Bu2B(OTf), 
EtN(i-Pr)2, MeCHO, DCM, –78 °C. c) 2a, Imidazole, TES-Cl, DCM, 0 °C to rt. 
 
Compounds 1-2b are known compounds and therefore only the spectroscopic data of 2b 
will be discussed in detail. The IR bands at 2995 (Ar), 1784 (C=O, carbamate) and 1696 (C=O, 
amide) were observed for 2b. The upfield resonances at 0.96 (t, J = 7.4 Hz, 9H, TES-Me) and 
0.61 (q, J = 7.4 Hz, 6H, TES-CH2) in the 
1H NMR spectrum confirmed the TES-PG in 2b. Two 
doublets at 1.20 and 1.12 ppm, each integrating for 3-protons were assigned to the methyl 
groups H-1 and H-4 respectively, while two quintet resonances at 4.25 and 3.91 ppm, each 











respectively. The resonances at 7.32 (m, 3H, Ar), 7.24 (m, 2H, Ar), 4.69 (m, 1H, H-b), 4.14 
(m, 2H, H-c) and 3.34 (dd, J = 13.3, 3.3 Hz, 1H, H-a) and 2.70 (dd, J = 13.3, 9.8 Hz, 1H, H-a) 
confirmed the CA protons. The diastereotopic benzylic protons appeared as a dd due to 
geminal coupling (J = 13.3 Hz) and vicinal coupling (J = 9.8, 3.3 Hz). The presence of two 
carbonyl peaks at 175.5 (C=O, carbamate) and 153.3 (C=O, amide) ppm in the 13C NMR 
spectrum confirmed the carbonyl groups in 2b. The resonance peaks in the aromatic region 
(136.0-128.0 ppm) were assigned to the Ph-carbons while 66.1 (C-2), 55.8 (C-b) and 45.0 (C-
3) were assigned to the methine carbons. The resonances at 69.8 (C-c), 40.0 (C-a) and 5.0 
(TES-CH2) were observed accordingly for the methylene carbons while 21.8 (C-1), 13.0 (C-4), 
and 7.0 (TES-Me) were observed for the methyl carbons. With the help of HSQC, the TES-
CH2 was assigned quite upfield, and was reasoned to arise due to shielding effect by the silyl 
group. The synthesis of 2b was further confirmed by an HRMS determination in which, 
HRMS (ES): m/z calc. 392.2252 for C21H34NO4Si, [M+H]
+ requires 392.2261. 
Now that the desired stereochemistry had been installed in 2b, the cleavage of the CA was 
pursued of which a plethora of reactions were available.52 In this research the CA was 
cleaved via the EtSLi SNAc reaction to give the thioester 3 in good yield (93 %) with a 90 % 
recovery of the CA.35, 53  
 
Scheme 7.2: Reaction conditions- a) i) n-BuLi, EtSH, THF, –78 °C; ii) 2b, THF, –78 to –50 °C. 
 
The disappearance of the 1784 (C=O, carbamate) and 1696 (C=O, amide) IR bands 
accompanied by the appearance of a 1688 (C=O thioester) band confirmed the facile 
cleavage of the CA. The thioethyl resonances observed at 2.85 (q, J = 7.4 Hz, 2H, H-5) and 
1.24 (t, J = 7.4 Hz, 3H, H-6) in the 1H NMR spectrum as well as the disappearance of the CA 
resonances at the respective chemical shifts confirmed 3. Also, in the 13C NMR spectrum 
the thioester carbonyl observed at 202.6 ppm accompanied by the disappearance of the 











at 23.4 (C-5) and 22.4 (C-6) with the disappearance of the CA carbons resonances, while all 
the other resonances were assigned similarly as before in both the 1H NMR and 13C NMR 
spectrum. A HRMS determination further confirmed product 3, HRMS (ES): m/z calc. 
276.1652 for C13H29O2SSi, [M + H]
+ requires 276.1657. 
 
The Ohira-Bestmann reagent i was readily accessed via an azide transfer reaction between 
p-tosyl azide and dimethyl (2-oxopropyl)phosphonate and was obtained in 60 % yield, 
Scheme 7.3 (Eqn 1).54 With the Ohira-Bestmann reagent in hand, 3 was subjected to DIBAL 
reduction to afford aldehyde 4, which was subsequently used without further purification 
with the Ohira-Bestmann homologation conditions (Eqn 2), Scheme 7.3. The alkyne TLC 
profile showed several spots which made the isolation of the product difficult to achieve. To 
try and improve the TLC profile various reaction conditions were sought including 
increasing the equivalents of i, lowering the reaction temperature, purifying the aldehyde 
(4, 60 % yield) and so on but unfortunately this did not improve the outcome.  
 
Scheme 7.3: Reaction condition- a) p-TosN3, NaH, THF, 0 °C. b) DIBAL-H, DCM, –78 °C. c) 
K2CO3, i, MeOH, rt. 
The Ohira-Bestmann homologation is an improvement on the Seyferth-Gilbert 
homologation and uses dimethyl (1-diazo-2-oxopropyl)phosphonate (DOPP) as opposed to 
the dimethyl (diazomethyl)phosphonate (DAMP) used in the Seyferth-Gilbert protocol.55 
The Seyferth-Gilbert homologation provides synthesis to alkynes via deprotonation of 
DAMP with a strong base (such as t-BuOK) to form a DAMP anion which adds to the 
aldehyde. By comparison, the Ohira-Bestmann modification uses DOPP and a mild base 











allows the conversion of base-labile substrates such as enolisable aldehydes, which tend to 
undergo aldol-condensation under the Seyferth-Gilbert conditions.56 During the Ohira-
Bestmann homologation, methanol (a relatively weak nucleophile) is thought to do a SNAc 
reaction with i in the presence of K2CO3 to give the resonance-stabilised DAMP anion which 
then adds to the aldehyde, Scheme 7.4. This is followed by an intramolecular addition to 
the electrophilic phosphonate ester by the alkoxide to form a Wittig-type oxaphosphetane 
intermediate that eliminates to form the diazo alkene. This intermediate then loses N2 to 
afford a carbene, which rapidly rearranges to the alkyne.  
 
Scheme 7.4: Ohira-Bestmann homologation mechanism. 
7.2. Route 2: synthesis of macrolide 10 via the Stork-Zhao olefination 
Since the Ohira-Bestmann homologation reaction did not work as well as anticipated, 
another route that could potentially use the intermediates already in hand was sought to 
establish the (Z-E)-diene moiety in 10.  
As with Route 1, the final step to 10 in Route 2 was envisaged to be achieved via an 
intramolecular HWE olefination of aldehyde 9, Scheme 7.5. The (Z-E)-diene moiety in 8 was 
thought to be accessed via a Suzuki cross-coupling reaction in which the coupling partners 
would be the cis-vinyl iodide 7 and (E)-(5-hydroxypent-1-en-1-yl)boronic acid iv. Compound 
7 was thought to be accessed similarly to the alkyne 5’, but instead of subjecting aldehyde 4 
to Ohira-Bestmann conditions it would be subjected to the Stork-Zhao olefination 
conditions to afford the cis-vinyl iodide 5. Indeed the Stork-Zhao olefination gave better 












Scheme 7.5: Route 2- retrosynthesis via the Stork-Zhao olefination. 
7.3. Macrolide 10 synthesis via Stork-Zhao olefination 
Aldehyde 4 was accessed as described above and was subjected without further 
purification to Stork-Zhao olefination conditions with ii (a commercially available synthon) 
to afford 5 in a moderate yield (57 %) over two steps, Scheme 7.6.57 In an attempt to 
improve the yield, the aldehyde was purified by column chromatography, which gave a 57 
% yield but this resulted in an even lower overall yield (5, 40 %). Although it was not clear 
how the moderate yields came about, one cannot rule out aldehyde decomposition. Also, it 
was noted that most examples found in the literature for similar reaction transformations 
obtained the respective cis-vinyl iodide also only in moderate to good (48-76 %) yields. 
 
Scheme 7.6: Reaction conditions- a) DIBAL, DCM, –78 °C. b) i) NaHMDS, ii, THF, 0 °C to rt, ii) 
4, THF, –50 to 0 °C. 
 
The Stork-Zhao olefination is a subclass of the Wittig olefination reaction and uses an 
unstabilised ylide to synthesise cis-vinyl halides.57 The reaction mechanism of the Stork-











NaHMDS to afford the ylide which in turn adds to 4, and thereafter the normal Wittig 
mechanism applies, Scheme 7.7. Unstabilised ylides are known to be Z-olefin selective due 
to the irreversible formation of the cis-oxaphosphetane (kinetically favoured over 
formation of the anti-isomer), which collapses to the kinetic product, the Z-isomer. The 
presence of an electron-withdrawing group in stabilised ylides allows equilibration to the 
more stable anti-oxaphosphetane which collapses to the thermodynamic product, the E-
isomer (vide infra).  
 
Scheme 7.7: Stork-Zhao olefination reaction mechanism.  
 
The IR spectrum of 5 showed the disappearance of the carbonyl band with the appearance 
of the alkene band at 2957 cm-1. New resonances at 6.26 (d, J = 9.2 Hz, 1H, H-6) and 6.07 
(dd, J = 9.2, 6.4 Hz, 1H, H-5) were observed for the cis-alkene illustrating the lower coupling 
constant compared to that of the (E)-isomer. The 13C NMR spectrum also confirmed the 
disappearance of the carbonyl resonance with the appearance of two alkene peaks at 144.4 
(C-5) and 81.5 (C-6). The resonance for C-6 was observed quite upfield (81.5 ppm) due to 
the shielding effect by the iodine group attached to it. All the other 1H NMR and 13C NMR 
resonances were observed similarly as before and were assigned accordingly.  
Although the cis-vinyl iodide was obtained in modest overall yields it was thought best to 
continue with the macrolide synthesis. Moving forward, the silyl-PG was deprotected with 
TBAF to afford alcohol 6 in good yield (75 %).64 Owing to the low carbon percentage by-
mass and the presence of the vinyl halide moiety, compound 6 was found to be relatively 











avoid loss of the product. Also, vinyl iodides are known to be light sensitive, so the product 
was exposed to minimum light as possible and used immediately in the next step.58  
 
Scheme 7.8: Reaction conditions- a) TBAF, THF, 0 °C to rt.  
 
The presence of the O-H band at 3351 cm-1 as well as the disappearance of the 
triethylsilane resonances in both the 1H NMR and 13C NMR spectrum at the diagnostic 
regions was indicative of a successful deprotection. All the other resonances shifted slightly 
downfield because of the withdrawing effects from the hydroxyl group in 6 and were 
assigned accordingly as in 5.  
Commercially available 2-(dimethoxyphosphoryl) acetic acid was treated with oxalyl 
chloride to afford iii (Eqn 1), which was sufficiently pure to be used without further 
purification, Scheme 7.9.59 Alcohol 6 was acylated with iii to afford 7 (80 % yield) (Eqn 2) in 
preparation for an intramolecular HWE reaction to be carried out in the last step. In such a 
way, the first cross-coupling partner (the cis-vinyl halide) of the Suzuki reaction had been 
obtained over eight linear steps. 
 
Scheme 7.9: a) DMF, (COCl)2, DCM. b) DMAP, Pyridine, iii, 0 °C to rt.  
 
The disappearance of the O-H stretch at 3351 cm-1 in 6 accompanied by a new C=O stretch 
at 1730 cm-1 in the IR spectrum of 7 confirmed the acylation of 6 to 7. The new resonances 











1.7 Hz, 1H, H-7) and 2.98 (dd, J = 12.6, JH-P = 1.7 Hz, 1H, H-7) in the 
1H NMR spectrum were 
assigned to the phosphonate ester. In the 1H NMR spectrum, apart from normal H-H 
couplings, the phosphonate ester resonances experienced additional coupling to 
phosphorus resulting in the additional doubling of peaks (13P, I = 0.5). The phosphonate 
ester 13C NMR resonances observed C-P coupling too to give doublets: 165.3 (d, JC-P = 6.4 
Hz, C=O), 53.3 (d, JC-P = 7.5 Hz, OMe), 53.3 (d, JC-P = 6.4 Hz, OMe), 33.8 (d, JC-P = 10.5 Hz, C-7). 
Other resonances were observed as before and assigned accordingly. A HRMS 
determination further confirmed 7, with HRMS: m/z calc. 377.0009 for C10H19IO5P, [M + H]
+ 
requires 377.0012. 
To access the second coupling partner (the boronic acid), pent-4-yn-1-ol was treated with 
catecholborane to afford iv after work-up in 40 % yield (Eqn 1).60 Subjecting 7 and iv to 
Suzuki cross-coupling conditions afforded the (E,Z)-diene 8 in good yield 70 % (Eqn 2).61  
 
Scheme 7.10: Reaction conditions- a) Catecholborane, pent-4-yn-1-ol, 66 °C, THF : H2O (3 : 
1); b) iv, 7, THF : H2O (3 : 1), Pd(PPh3)4, TlOEt.  
 
The Suzuki cross-coupling reaction mechanism commences with the oxidative addition of 
Pd (0) to the cis-vinyl iodide (R1X) forming Pd (II) species A, Scheme 7.11. A transmetallation 
between A and thallium ethoxide affords intermediate B which in turn undergoes a second 
transmetallation to give the cross-coupled organopalladium C. The organopalladium species 
C collapses via reductive elimination to give the (E,Z)-diene R1-R2 8, restoring the catalyst as 












Scheme 7.11: Suzuki cross-coupling reaction mechanism. 
 
A new IR band at 3429 cm-1 for the O-H group was observed in 8 while the C=O band at 
1739 was observed as in 7. The resonances at 6.31 (dd, J = 14.0, 10.1 Hz, 1H, H-6), 6.01 (t, J 
= 10.1 Hz, 1H, H-5), 5.72 (dt, J = 14.0, 7.0 Hz, 1H, H-8) and 5.11 (t, J = 14.0 Hz, 1H, H-7) in the 
1H NMR spectrum were assigned to the (E,Z)-diene. In order to explain the observed J-
values, compound 8 has to be drawn as shown in Figure 7.1, the speculated lower energy 
conformer. The observed J-values for H-6 arise due to the cis-coupling to H-5 (11.1 Hz) and 
the trans-coupling to H-7 (14.0 Hz). H-5 is a triplet with (cis,cis)-coupling to H-6 and H-3 
having J = 10.1 Hz. H-7 is another triplet with a (trans,trans)-coupling to H-6 and H-8 having 
J = 14.0 Hz, while H-8 couples to H-7 (J = 14.0 Hz) and the methylene protons, H-9 (J = 7.0 
Hz). Three new resonance peaks at 3.66 (q, J = 6.2 Hz, 2H, H-11), 2.21 (m, 2H, H-10) and 
1.68 (m, 2H, H-9) were observed and assigned to the three-methylene protons. The 
resonances at 135.3 (C-8), 130.5 (C-7), 129.8 (C-5) and 126.2 (C-6) in the 13C NMR spectrum 
were assigned to the (E,Z)-diene while 62.4 (C-11), 32.3 (C-10) and 29.2 (C-9) were assigned 
to the methylene carbons, all together confirming 8. Resonance C-6 shifted downfield from 
83.3 to 126.2 ppm as a result of the (E,Z)-diene conjugation present in 8. All the other 
resonances were observed similarly as in 7 for both the 1H NMR and 13C NMR spectrum. 
The phosphorus-couplings were again observed as before in the 1H NMR and 13C NMR 
spectra. Further evidence for 8 was given by mass spectrometry, HRMS (ES): m/z calc. 
335.1618 for C15H28O6P, [M + H]












Figure 7.1: The J-coupling constants for compound 8. 
 
Now that the (E,Z)-diene moiety had been installed we sought to construct the lactenone 
moiety by an intramolecular cyclization to macrolide 10. To do so, alcohol 8 was oxidised 
via the well-known Dess-Martin periodinane (DMP) oxidation protocol to afford 9 in a 
moderate yield of 59 %, the aldehyde once again proving difficult to purify.62  
 
Scheme 7.12: Reaction conditions- a) 8, DMP, NaHCO3, DCM, rt.  
 
The replacement of the O-H band at 3429 cm-1 by a C=O band at 1725 cm-1 in the IR 
spectrum confirmed the synthesis of 9. A conspicuous aldehyde resonance was observed at 
9.98 ppm with the disappearance of the H-11 methylene protons at 3.66 ppm in the 1H 
NMR spectrum, also supporting the oxidation. A new carbonyl resonance peak in the 13C 
NMR spectrum observed at 201.7 ppm for the –CHO group and the disappearance of the C-
11 methylene resonance, also confirmed the oxidation. All the other resonances were 
observed as before with a slight downfield shift, which was significant for the methylene (H-
/C-10) next to the aldehyde due to the electron withdrawing effects of the –CHO group. 
Aldehyde 9 was further confirmed by mass spectrometry, HRMS (ES): m/z calc. 333.1462 for 
C15H26O6P, [M + H]











Finally, 9 was subjected to a HWE olefination to afford macrolide 10 in a good yield of 72 
%.63 Using the crude aldehyde residue from the previous step only slightly increased the 
yield to 76 %. The HWE olefination is another subclass of the Wittig olefination except 
involves a stabilised carbanion for the synthesis of E-olefins and goes via a similar 
mechanism as the one described above for the synthesis of the cis-vinyl iodide.  
 
Scheme 7.13: Reaction conditions- a) Zn(OTf)2, TMEDA, TEA, 9 (1.5 mM), THF, rt. 
 
The mild conditions used in this synthesis were inspired by Pirrung et al in his total 
synthesis of Syringolin A and B.63 Stronger bases were avoided as they could have enolised 
the aldehyde moiety to promote an aldol addition instead of the desired olefination 
reaction. Zinc-triflate (a Lewis acid) coordinates to the ester and in so doing increases the 
acidity of the α-protons for deprotonation by a mild base such as triethylamine (TEA), 
Scheme 7.14. Also, the zinc-triflate is thought to coordinate to the aldehyde moiety as well, 
and in so doing it brings the two reacting groups into close proximity, thus favouring the 
intramolecular olefination. TMEDA is used to mop-up triflic acid that may form and 
consequently hinder the reaction progression. High dilutions (1.5 mM) were used in this 
reaction to favour an intramolecular cyclisation as opposed to an intermolecular variant 












Scheme 7.14: The intramolecular HWE reaction mechanism. 
 
The disappearance of the aldehyde C=O stretch at 1729 cm-1 in 9 accompanied by the 
appearance of a lactone carbonyl at 1723 cm-1 in 10 supported the formation of 10. The 
disappearance of the phosphonate methoxy resonances in the 1H NMR spectrum also 
supported this. The resonances at 6.43 (m, 1H, H-11) and 5.49 (d, J = 15.1 Hz, 1H, H-12) 
were assigned to the newly formed E-olefin. H-6 no longer appeared as a dd with 
(cis,trans)-coupling but was observed as a triplet with (cis,cis)-coupling due to 
conformational change in the C6-C7 bond upon cyclisation and this further confirms 
macrolide 10. Also, the multiplicity of H-7 changed from a triplet to a dd for the same 
reasons as H-6. The 13C NMR spectrum also showed the disappearance of the phosphonate 
methoxy carbon resonances as well as the downfield shifting of C-12 from 34.2 to 128.7 
ppm, confirming the newly installed enone. Finally, mass spectrometry confirmed 
macrolide 10, with HRMS (ES): calc. 207.1380 for C13H18O2, [M + Na]

















Chapter 8: Conclusion and Future work 
8.1. Conclusion 
A versatile synthesis of macrolide core (10) of lactimidomycin has been achieved in 11-
linear steps in 6.1 % overall yield. The synthesis exploited three core reactions to construct 
the pivotal sites in 10 and those include Evans oxazolidinone-mediated aldol reaction (for 
the contiguous syn-stereocentres), the Suzuki cross-coupling to access the (E,Z-diene), and 
finally the Horner-Wadsworth-Emmons olefination to construct the enone and cyclise 
simultaneously. 
8.2. Future work 
Exploiting this synthesis, a versatile library of lactimidomycin can be rapidly accessed by 
small variations, Figure 8.1. Once the analogues have been obtained they can all be 
evaluated for biological activity including 10. 
  

























Chapter 9: Experimental 
9.1. General 
All reagents and solvents were purchased from Sigma-Aldrich or Fischer Scientific and were 
used without further purification unless stated.  
All reactions were carried out in oven dry glassware with a magnetic stirrer. All reactions 
were done under nitrogen atmosphere unless stated. Reaction solvents including THF, 
DCM, toluene and Et2O were filtered through a column (Innovative Technologies) of 
activated alumina under nitrogen atmosphere. Reaction temperatures were achieved via: 
heat/silicone oil bath (for Temp > 25 °C), ice bath (for Temp ≈ 0 °C), Neslab CB 80 immersion 
cooler (–20 to –60 °C), or acetone/dry ice bath (for –78 °C). Aqueous solutions were 
prepared using deionized water. All solvents used for extractions and column 
chromatography were either ACS- or HPLC-grade. Crude mixtures were purified by flash 
chromatography using SiliCycle SiliaFlash P60 (230-400 m sh) silica gel. 
Nuclear Magnetic Resonance (NMR) spectra were recorded on either Varian vnmrs 700 
(700 MHz), Varian vnmrs 500 (500 MHz), Varian INOVA 500 (500 MHz), or Varian MR400 
(401 MHz) spectrometers and chemical shifts (δ) are reported in ppm while the J-coupling 
constants are recorded in Hz. Chemical shifts for 1H and 13C were recorded relative to 
residual chloroform, 7.26 and 77.16 ppm respectively. High resolution mass spectra (HRMS) 
were recorded on Micromass AutoSpec Ultima or VG (Micromass) 70-250-S magnetic sector 
mass spectrometers in the University of Michigan mass spectrometry laboratory. Infrared 
(IR) spectra were performed on a Perkin Elmer Spectrum BX FT-IR spectrometer. Absorption 
peaks were reported in wavenumbers (cm-1). Optical rotations were measured on a JASCO 
P-2000 or Autopol III digital polarimeter at 589 nm (D-line) and are reported as:     
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9.2. Synthesis of macrolide 10 
(4R)-4-benzyl-3-propionyloxazolidin-2-one9b, 51 (1) 
 
To a solution of (R)-4-benzyloxazolidin-2-one (2.00 g, 11.29 mmol) in dry THF (23.00 ml) at –
78 °C was added slowly n-BuLi (5.42 ml, 13.54 mmol, 2.5 M, 1.2 eq) and the contents 
allowed to stir at this temperature. After 30 min, propionyl chloride (1.47 ml, 16.93 mmol, 
1.5 eq) was added slowly at –78 °C and the contents allowed to slowly warm up to 0 °C over 
2 hrs. The reaction was quenched with sat. NH4Cl (45 ml) and warmed to ambient 
temperature and extracted with DCM (3 x 40 ml). The organic extracts were dried over 
MgSO4, concentrated in vacuo, and the crude residue purified by column chromatography 
(10 % EtOAc in hexane) to obtain 1 (2.40 g, 91 % yield) as a colourless oil. The 1H NMR 
spectrum agreed with literature data.  
1H NMR (401 MHz, CDCl3) δ 7.29 (m, 3H, H-3’ + H-4’), 7.20 (m, 2H, H-2’), 4.66 (m, 1H, H-b), 
4.17 (m, 2H, H-c), 3.29 (dd, J = 13.4, 3.2 Hz, 1H, H-a), 2.95 (m, 2H, H-2), 2.76 (dd, J = 13.4, 
9.6 Hz, 1H, H-a), 1.19 (t, J = 7.3 Hz, 3H, H-1). 
 
(4R)-4-benzyl-3-((2’R,3’S)-3’-hydroxy-2’-methylbutanoyl)oxazolidin-2-one9b, 51 (2a) 
 
To a solution of 1 (2.296 g, 9.840 mmol) in DCM (9.0 ml) under argon atmosphere at –78 °C 
was added slowly dibutylboron triflate (14.76 ml, 14.76 mmol, 1.5 eq, 1.0 M) followed by i-
Pr2NEt (3.09 ml, 17.71 mmol, 1.8 eq) and allowing the contents to slightly warming up to –
45 °C. After 1 hr, the contents were re-cooled to –78 °C and freshly distilled acetaldehyde 
(2.20 ml, 39.36 mmol, 4.0 eq) was added and the reaction mixture allowed to warm up to –
10 °C over 2 hrs. Upon completion, the reaction was quenched with MeOH : H2O2 (30 %) : 











was concentrated in vacuo, sat. NaHCO3 (30 ml) added and extracted with EtOAc (2 x 30 
ml). The organic extracts were further washed with sat. NaCl (30 ml), re-extracted with 
EtOAc (3 x 40 ml), combined and dried over MgSO4, concentrated in vacuo and the crude 
residue purified by column chromatography (40 % EtOAc in Hexane) to obtain 2a (2.05 g, 75 
% yield) as a colourless oil. The 1H NMR spectrum agreed with literature data.9b, c 
1H NMR (401 MHz, CDCl3) δ 7.32 (m, 3H, H-3’ + H-4’), 7.21 (m, 2H, H-2’), 4.71 (m, 1H, H-b), 
4.22 (m, 2H, H-c), 4.18 (m, 1H, H-2) 3.74 (qd, J = 7.1, 2.9 Hz, 1H, H-3), 3.25 (dd, J = 13.4, 3.4 
Hz, 1H, H-a), 2.90 (s, 1H, OH), 2.79 (dd, J = 13.4, 9.5 Hz, 1H, H-a), 1.27 (d, J = 7.1 Hz, 3H, H-




To a solution of 2a (2.00 g, 7.21 mmol) in DCM (10 ml) at 0 °C was added a solution of 
imidazole (1.44 g, 21.19 mmol, 2.8 eq) in DCM (7.0 ml). After 30 min, TES-Cl (1.69 ml, 10.10 
mmol, 1.4 eq) was added at 0 °C and the contents allowed to slowly warm up to rt. After 5 
hrs, sat. NaHCO3 (30 ml) was added, the reaction contents extracted with DCM (3 x 40 ml), 
the organic extracts combined, dried over MgSO4 and concentrated in vacuo. The crude 
mixture was purified by column chromatography (10 % EtOAc in hexane) to obtain 2b 
(2.661 g, 94 % yield) as a colourless oil. 
    
    –64.9, (DCM, c = 2.0); νmax (cm
-1) 2995 (Ar), 1784 (C=O, carbamate), 1696 (C=O, 
amide); 1H NMR (401 MHz, CDCl3) δ 7.32 (m, 3H, H-3’ + H-4’), 7.24 (m, 2H, H-2’), 4.73-4.65 
(m, 1H, H-b), 4.25 (p, J = 6.2 Hz, 1H, H-2), 4.20-4.10 (m, 2H, H-c), 3.91 (p, J = 6.2 Hz, 1H, H-3), 
3.34 (dd, J = 13.3, 3.3 Hz, 1H, H-a), 2.70 (dd, J = 13.3, 9.8 Hz, 1H, H-a), 1.20 (d, J = 6.2 Hz, 3H, 
H-1), 1.12 (d, J = 6.2 Hz, 3H, H-4), 0.96 (t, J = 7.4 Hz, 9H, TES-Me), 0.61 (q, J = 7.4 Hz, 6H, TES-
CH2); 
13C NMR (126 MHz, CDCl3) δ 175.5 (C=O, carbamate), 153.3 (C=O, amide), 135.6 (C-1’), 











21.8 (C-1), 13.0 (C-4), 7.0 (TES-Me), 5.0 (TES-CH2); HRMS (ES): m/z calc. for C21H34NO4Si, 
[M+H]+ requires 392.2252 requires 392.2261.  
 
(2R,3S)-S-ethyl 2-methyl-3-((triethylsilyl)oxy)butanethioate35 (3) 
 
To a solution of ethanethiol (0.24 ml, 3.22 mmol, 1.4 eq) in THF (2.0 ml) at –78 °C was added 
n-BuLi (1.11 ml, 2.76 mmol, 1.2 eq, 2.5 M). After 30 min, a solution of 2b (0.904 g, 2.303 
mmol) in THF (5.0 ml) was slowly added at –78 C and the contents allowed to warm to –50 
C. After 1 hr, the reaction was quenched with sat. NH4Cl (40 ml) and extracted with DCM (3 
x 50 ml). The organic fractions were combined, dried over MgSO4, concentrated in vacuo 
and the crude residue purified by column chromatography (1 % EtOAc in hexane) to give 3 
(0.595 g, 93 %) as a colourless liquid and the auxiliary recovered as colourless solid (93 %, 
0.380 g).  
    
    –10.8, (DCM, c = 1.0); νmax (cm
-1) 1688 (C=O, thioester); 1H NMR (500 MHz, CDCl3) δ 
4.00 (p, J = 6.2 Hz, 1H, H-2), 2.85 (q, J = 7.4 Hz, 2H, H-5), 2.59 (p, J = 6.4 Hz, 1H, H-3), 1.24 (t, 
J = 7.4 Hz, 3H, H-6), 1.19 (d, J = 6.2 Hz, 3H, H-1), 1.16 (d, J = 6.4 Hz, 3H, H-4), 0.95 (t, J = 7.6 
Hz, 9H, TES-Me), 0.59 (q, J = 7.6 Hz, 6H, TES-CH2); 
13C NMR (126 MHz, CDCl3) δ 202.6 (C=O, 
thioester), 70.1 (C-2), 56.8 (C-3), 23.4 (C-5), 22.4 (C-6), 14.8 (C-1), 14.1 (C-4), 7.0 (TES-Me), 
5.1 (TES-CH2); HRMS (ES): m/z calc. 276.1652 C13H29O2SSi, [M+H]
+ requires 276.1657. 
 
(2R,3S)-2-Methyl-3-((triethylsilyl)oxy)butanal (4)  
 
To a solution of 3 (1.00 g, 3.61 mmol) in DCM (8.0 ml) at –78 °C was slowly added (over 15 
min) DIBAL (4.34 ml, 4.34 mmol, 1.15 eq, 1.0 M). After 30 min at –78 °C, the reaction was 











Thereafter, sat. Rochelle’s salt (15 ml) was added, the reaction contents diluted with EtOAc 
(20 ml) and allowed to stir for further 30 min. The reaction was extracted with EtOAc (2 x 20 
ml), the organic extracts washed with sat. NaCl (30 ml) and re-extracted with EtOAc (3 x 30 
ml). The organic extracts were combined, dried over MgSO4 and concentrated in vacuo to 
afford the crude mixture of aldehyde 4, which was used without further in the next step.  
 
Dimethy (1-diazo-2-oxopropyl)phosphonate54  (i) 
 
To a solution of dimethyl (2-oxopropyl)phosphonate (1.00 g, 6.02 mmol) and p-Ts-azide 
(2.37 mg, 12.04 mmol, 2.0 eq) in THF (12 ml) was added triethylamine (1.26 ml, 9.03 mmol, 
1.5 eq) and the contents allowed to stir at ambient temperature. After 8 hrs, the contents 
were filtered in vacuo and washed with EtOAc (20 ml). Thereafter, the organic extracts 
were washed with sat. NaCl (30 ml), extracted with EtOAc (3 x 20 ml), organic extracts 
combined and dried over MgSO4 and concentrated in vacuo. The crude mixture was flashed 
on a small column (60 % EtOAc in hexane) to afford i (0.693 g, 60 % yield) as a colourless oil. 
1H NMR (700 MHz, CDCl3) δ 3.78 (d, J = 3.2 Hz, 3H, OMe), 3.72 (d, J = 3.2 Hz, 3H, OMe), 2.17 
(s, 3H, Me). 
 
Triethyl(((2S,3S,Z)-5-iodo-3-methylpent-4-en-2-yl)oxy)silane (5)  
  
To a solution of ii (6.04 g, 11.39 mmol, 3.2 eq) in THF (12 ml) was added NaHMDS (10.84 ml, 
1.0 M, 10.84 mmol, 3.0 eq) at ambient temperature and the solution stirred for 30 min. 
Thereafter, the reaction was cooled to –78 °C followed by slow addition of crude aldehyde 
4 (0.782 g, 3.61 mmol) allowing the contents to warm up to –20 °C. After 2 hrs, sat. NH4Cl 











with DCM (3 x 40 ml), the organic extracts dried over MgSO4 and concentrated in vacuo. 
The concentrate was purified by column chromatography (5 % EtOAc in hexane) to afford 
the cis-vinyl iodide 5 (0.700 g, 57 % yield) as a colourless oil.  
    
  = 36.2, (DCM, c = 1.0); νmax (cm
-1) 2957 (alkene); 1H NMR (700 MHz, CDCl3) δ 6.18 (d, J 
= 9.2 Hz, 1H, H-6), 6.06 (dd, J = 9.2, 6.4 Hz, 1H, H-5), 3.76 (p, J = 6.4 Hz, 1H, H-2), 2.52-2.49 
(m, 1H, H-3), 1.15 (d, J = 6.4 Hz, 3H, H-1), 0.99 (d, J = 6.4 Hz, 3H, H-4), 0.96 (t, J = 7.4 Hz, 9H, 
TES-Me), 0.60 (q, J = 7.4 Hz, 6H, TES-CH2); 
13C NMR (176 MHz, CDCl3) δ 144.4 (C-5), 81.5 (C-




To a solution of 5 (0.700 g, 2.06 mmol) in THF (5.0 ml) at 0 °C was added TBAF (2.67 ml, 2.67 
mmol, 1.0 M, 1.3 eq) and contents allowed to slowly warm up to rt. After 2 hrs, sat. NaHCO3 
(20 ml) was added, the reaction extracted with DCM (3 x 30 ml), the organic extracts dried 
over MgSO4 and concentrated in vacuo. The concentrate was purified by column 
chromatography (10 % EtOAc in hexane) to afford 7 (0.372 g, 80 % yield) as a colourless oil. 
    
  = –26.8, (DCM, c = 1.0); νmax (cm
-1) 3351 (O-H), 2971 (alkene); 1H NMR (500 MHz, 
CDCl3) δ 6.26 (d, J = 9.2 Hz, 1H, H-6), 6.07 (dd, J = 9.2, 6.4 Hz, 1H, H-5), 3.77 (p, J = 6.3 Hz, 
1H, H-2), 2.61-2.55 (m, 1H, H-3), 1.20 (d, J = 6.3 Hz, 3H, H-1), 1.04 (d, J = 6.6 Hz, 3H, H-4); 13C 
NMR (176 MHz, CDCl3) δ 143.3 (C-5), 82.6 (C-6), 70.9 (C-2), 46.7 (C-3), 21.0 (C-1), 14.7 (C-4). 
 
Dimethyl (2-chloro-2-oxoethyl)phosphonate (iii) 
 
To a solution of 2-(dimethoxyphosphoryl) acetic acid (0.840 g, 5.00 mmol) and DMF (0.1 ml, 











°C. The mixture was stirred at room temperature for 1 hr before the solvent was removed 
in vacuo. The acyl chloride iii was dried under high vacuum for 2 hrs before it was used. 
 
(2S,3S,Z)-5-iodo-3-methylpent-4-en-2-yl 2-(dimethoxyphosphoryl)acetate (7)  
 
To a solution of 6 (0.653 g, 2.89 mmol) and DMAP (0.177 g, 1.446 mmol, 0.5 eq) in DCM (8.0 
ml) at ambient temperature was added pyridine (1.21 ml, 15.035 mmol, 5.2 eq). Thereafter, 
the reaction contents were cooled to 0 °C followed by slow addition of iii (11.56 ml, 11.56 
mmol, 1.0 M, 4.0 eq) in DCM and the contents allowed to warm up to rt. After 2 hrs, HCl 
(15.0 ml, 1.0 N) and CuSO4 (15.0 ml, 1.0 M) were added and contents allowed to stir for 1 
hr. Thereafter, sat. NaHCO3 (20.0 ml) was added and the reaction mixture extracted with 
DCM (3 x 40 ml). The organic extracts were dried over MgSO4, concentrated in vacuo, and 
the concentrate purified by column chromatography (30 % EtOAc in hexane) to afford 7 
(0.761 g, 70 % yield) as a light yellow oil. 
    
  = 20.2, (DCM, c = 1.0); νmax (cm
-1) 2971 (alkene), 1730 (C=O); 1H NMR (400 MHz, CDCl3) 
δ 6.30 (d, J = 9.2 Hz, 1H, H-6), 6.04 (dd, J = 9.2, 6.4 Hz, 1H, H-5), 4.93 (p, J = 6.4 Hz, 1H, H-2), 
3.83 (d, JH-P = 1.5 Hz, 3H, OMe), 3.80 (d, JH-P = 1.5 Hz, 3H, OMe), 3.01 (dd, J = 12.6, JH-P = 1.7 
Hz, 1H, H-7), 2.98 (dd, J = 12.6, JH-P = 1.7 Hz, 1H, H-7), 2.81-2.73 (m, 1H, H-3), 1.25 (d, J = 6.4 
Hz, 3H, H-1), 1.04 (d, J = 6.4 Hz, 3H, H-4); 13C NMR (126 MHz, CDCl3) δ 165.3 (d, JC-P = 6.4 Hz, 
C=O ester), 142.1 (C-5), 83.3 (C-6), 74.5 (C-2), 53.4 (d, JC-P = 7.5 Hz, OMe), 53.3 (d, JC-P = 7.5 
Hz, OMe), 44.3 (C-3), 34.3 (d, JC-P = 10.5 Hz, C-7), 17.6 (C-1), 15.0 (C-4); HRMS (ES): m/z calc. 
377.0009 for C10H19IO5P, [M + H]

















(2S,3S,4Z,6E)-10-hydroxy-3-methyldeca-4,6-dien-2-yl 2-(dimethoxyphosphoryl)acetate (8)  
  
Compound 7 (0.200 g, 0.532 mmol) and the boronic acid iv60 (0.105 g, 0.744 mmol, 1.4 eq) 
were dissolved in (THF : H2O, 3 : 1, 5.0 ml). To this mixture was added a sonicated solution 
of Pd(PPh3)4 (0.061 g, 0.053 mmol, 0.1 eq) in (THF : H2O, 3 : 1, 1.5 ml) followed by TlOEt 
(124 μl, 0.175 mmol, 0.35 eq). After 30 min, pH 7 buffer (15 ml) was added and the 
contents allowed to stir for 30 min. Thereafter, the reaction mixture was extracted with 
EtOAc (3 x 25 ml), the organic extracts washed with sat. NaCl (35 ml), re-extracted with 
EtOAc (3 x 35 ml), dried over MgSO4 and concentrated in vacuo. The crude residue was 
purified by column chromatography (20 % EtOAc in hexane) to afford 8 (0.124 g, 70 %) as a 
yellowish oil. 
    
  = –2.0, (DCM, c = 1.0); νmax (cm
-1) 3429 (O-H), 2931 (alkene), 1739 (C=O); 1H NMR (400 
MHz, CDCl3) δ 6.31 (dd, J = 14.0, 10.1 Hz, 1H, H-6), 6.01 (t, J = 10.1 Hz, 1H, H-5), 5.72 (dt, J = 
14.0, 7.0 Hz, 1H, H-8), 5.11 (t, J = 14.0 Hz, 1H, H-7), 4.80 (p, J = 6.4 Hz, 1H, H-2), 3.83 (d, JH-P 
= 3.1 Hz, 3H, OMe), 3.80 (d, JH-P = 3.1 Hz, 3H, OMe), 3.66 (q, J = 6.2 Hz, 2H, H-11), 3.00 (dd, J 
= 12.6, JH-P = 1.7 Hz, 1H, H-12), 2.94 (dd, J = 12.6, JH-P = 1.7 Hz, 1H, H-12), 2.92-2.80 (m, 1H, 
H-3), 2.24-2.19 (m, 2H, H-10), 1.72-1.64 (m, 2H, H-9), 1.20 (d, J = 6.4 Hz, 3H, H-1), 1.01 (d, J 
= 6.4 Hz, 3H, H-4); 13C NMR (126 MHz, CDCl3) 165.3 (d, JC-P = 6.4 Hz, C=O ester), 135.3 (C-8), 
130.5 (C-7), 129.8 (C-5), 126.2 (C-6), 76.2 (C-2), 62.4 (C-11), 53.3 (d, JC-P = 7.5 Hz, OMe), 53.3 
(d, JC-P = 6.4 Hz, OMe), 37.2 (C-3), 34.5 (d, JC-P = 10.5 Hz, C-12), 32.3 (C-10), 29.2 (C-9), 17.4 
(C-1), 17.2 (C-4); HRMS (ES): m/z calc. 335.1618 for C15H28O6P, [M + H]

















(2S,3S,4Z,6E)-3-methyl-10-oxodeca-4,6-dien-2-yl 2-(dimethoxyphosphoryl)acetate (9) 
 
To a suspension of 8 (0.200 g, 0.592 mmol) and NaHCO3 (0.058 g, 0.688 mmol, 1.15 eq) in 
DCM (6.0 ml) was added a sonnicated solution of DMP (0.507 g, 1.196 mmol, 2.0 eq) in 
DCM (2.5 ml). After 2.5 hrs, the mixture was diluted with sat. NaHCO3 (20 ml), extracted 
with DCM (3 x 25 ml), the organic extracts dried over MgSO4 and organic solvents removed 
in vacuo. The crude residue was purified by column chromatography (20 % EtOAc in 
hexane) to afford aldehyde 9 (0.113 g, 59 %) as a colourless oil. 
    
  = 5.2, (DCM, c = 1.0); νmax (cm
-1) 2958 (alkene), 1739 (C=O, ester), 1725 (C=O, 
aldehyde); 1H NMR (700 MHz, CDCl3) δ 9.78 (t, J = 1.4 Hz,1H, H-11), 6.30 (dd, J = 14.0, 10.0 
Hz, 1H, H-6), 5.97 (t, J = 10.0 Hz, 1H, H-5), 5.69 (dt, J = 14.0, 6.8 Hz, 1H, H-8), 5.14 (t, J = 14.0 
Hz, 1H, H-7), 4.78 (p, J = 6.4 Hz, 1H, H-2), 3.82 (d, JH-P = 3.1 Hz, 3H, OMe), 3.79 (d, JH-P = 3.1 
Hz, 3H, OMe), 3.00 (dd, J = 12.6, JH-P = 1.7 Hz, 1H, H-12), 2.94 (dd, J = 12.6, JH-P = 1.7 Hz, 1H, 
H-12), 2.84-2.75 (m, 1H, H-3), 2.58-2.54 (m, 2H, H-10), 2.47-2.42 (m, 2H, H-9), 1.19 (d, J = 
6.3 Hz, 3H, H-1), 1.01 (d, J = 6.4 Hz, 3H, H-4); 13C NMR (176 MHz, CDCl3) δ 201.7 (C-11), 
165.4 (d, JC-P = 6.4 Hz, C=O ester), 133.2 (C-8), 131.5 (C-7), 129.3 (C-5), 126.8 (C-6), 76.0 (C-
2), 53.4 (d, JC-P = 6.4 Hz, OMe), 53.3 (d, JC-P = 6.4 Hz, OMe), 43.4 (C-10), 37.4 (C-3), 33.5 (d, JC-
P = 10.5 Hz, C-12), 25.5 (C-9), 17.8 (C-1), 17.1 (C-4); HRMS (ES): m/z calc. for 333.1462 
C15H26O6P, [M + H]


















(3E,7E,9Z,11S,12S)-11,12-dimethyloxacyclododeca-3,7,9-trien-2-one (10)  
 
To a suspension of Zn(OTf)2 (0.199 g, 0.546 mmol, 2.2 eq) in THF (35 ml) under argon 
atmosphere was added TMEDA (44 µl, 0.298 mmol, 1.2 eq) followed by TEA (138 µl, 0.993 
mmol, 4.0 eq) and the contents further diluted with THF (100 ml). After 30 min, a solution 
of aldehyde 9 (83 mg, 0.248 mmol) in THF (25 ml) was slowly added over 45 min. After 24 
hrs, excess THF was removed in vacuo and sat. NaCl (20 ml) added. The contents were 
extracted with EtOAc (2 x 20 ml), organic extracts combined and washed with HCl (25 ml, 1 
% M), back extracted with EtOAc (2 x 30 ml). Furthermore, the organic extracts were 
washed with NaHCO3 (25 ml), re-extracted with EtOAc (2 x 40 ml), the organic extracts 
dried over MgSO4 and concentrated in vacuo. The concentrate was purified by column 
chromatography to afford macrolide 10 (37 mg, 72 %) as a colourless oil. 
    
  = –42.9, (DCM, c = 1.0); νmax (cm
-1) 2936 (alkene), 1723 (C=O, ester); 1H NMR (700 
MHz, CDCl3) δ 6.48-6.38 (m, 1H, H-11), 6.11 (t, J = 10.8 Hz, 1H, H-6), 5.71 (dd, J = 14.7, 10.8 
Hz, 1H, H-7), 5.49 (d, J = 15.1 Hz, 1H, 12), 5.50-5.35 (m, 1H, H-8), 5.24-5.19 (m, 1H, H-5), 
5.11-5.05 (m, 1H, H-2), 3.10-3.02 (m, 1H, H-3), 2.60-2.48 (m, 2H, H-10), 2.00-1.80 (m, 2H, H-
9), 1.18 (d, J = 6.7 Hz, 3H, H-1), 0.97 (d, J = 6.7 Hz, 3H, H-4); 13C NMR (176 MHz, CDCl3) δ 
167.4 (C=O, ester), 146.3 (C-11), 134.7 (C-7), 130.7 (C-5), 130.0 (C-6), 128.7 (C-12), 128.1 (C-
8), 75.2 (C-2), 35.0 (C-3), 32.5 (C-10), 31.3 (C-9), 17.1 (C-1), 12.8 (C-4); HRMS (ES): m/z calc. 
207.1380 for C13H18O2, [M + H]


















Chapter 10: Summary 
 
The two research projects undertaken utilised chiral auxiliaries (CAs) to synthesise chiral 
synthons of chemical and biological importance. In both cases high diastereoselectivities 
were achieved and the products obtained in high yields. Overall, both research studies 
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